3rl1:A   (GLU212) to   (TRP274)  HIV RT DERIVED PEPTIDE COMPLEXED TO HLA-A*0301  |   HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM 
3rl2:A   (GLU212) to   (TRP274)  HIV NEF DERIVED PEPTIDE NEF73 COMPLEXED TO HLA-A*0301  |   HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM 
1a1n:A   (GLU212) to   (TRP274)  MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B3501, HIV, NEF, COMPLEX (ANTIGEN/PEPTIDE) 
1a1o:A   (GLU212) to   (TRP274)  MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B53, MALARIA, COMPLEX (ANTIGEN/PEPTIDE) 
4gt7:A   (THR369) to   (THR434)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
4gt7:A   (ASP473) to   (VAL543)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
4gt7:B   (THR369) to   (LYS435)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
4gt7:B   (ASP473) to   (VAL543)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
4gt7:C   (THR369) to   (THR434)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
4gt7:C   (ASP473) to   (VAL543)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
4gt7:D   (ASP473) to   (VAL543)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
4wdi:A   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
4wdi:D   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
1nak:I   (PRO151) to   (PRO227)  IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1nam:H   (ASP212) to   (TRP274)  MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX  |   T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM 
1nan:H   (ASP212) to   (TRP274)  MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE  |   CLASS I MHC, H-2KB, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM 
1nan:L   (ASP212) to   (TRP274)  MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE  |   CLASS I MHC, H-2KB, ALLOREACTIVITY, CROSSREACTIVITY, IMMUNE SYSTEM 
1a4k:H   (PRO149) to   (LYS209)  DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE  |   IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE 
1a4k:B   (PRO149) to   (PRO213)  DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE  |   IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE 
4web:L   (ASP149) to   (ARG217)  STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2  |   HEPATITIS C VIRUS, E2, IGG-LIKE FOLD, SCAVENGER RECEPTOR CLASS B TYPE I (SR-BI), CD81, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
1nd0:B   (GLY169) to   (PRO227)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:D   (GLY169) to   (PRO227)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:F   (GLY169) to   (PRO227)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:H   (GLY169) to   (PRO227)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1a6t:B   (PRO149) to   (PRO212)  FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE  |   IMMUNOGLOBULIN, NEUTRALIZES HUMAN RHINOVIRUS, IGG1 
4gw5:B   (PRO155) to   (PRO219)  CQYN MEDITOPE - CETUXIMAB FAB  |   IGG, IMMUNE SYSTEM, EGFR 
1a9e:A   (GLU212) to   (ARG273)  DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS  |   MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE) 
3ecb:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120  |   CLASS I MAJOR HISTOMPATIBILITY COMPLEX, MHC-I, H-2DD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, COILED COIL, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, LIPOPROTEIN, PALMITATE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM 
4wi4:A   (PRO271) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi4:B   (PRO271) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi5:A   (PRO271) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi5:B   (PRO271) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
2ojz:H   (GLY169) to   (PRO227)  ANTI-DNA ANTIBODY ED10  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4wj5:A   (GLU212) to   (TRP274)  STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE  |   ANTIGEN PRESENTATION, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA-A2 ANTIGEN, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
2av1:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.  |   TAX PEPTIDE, MHC, MUTATED HLA-A2, E63Q, K66A, IMMUNE SYSTEM 
2av1:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.  |   TAX PEPTIDE, MHC, MUTATED HLA-A2, E63Q, K66A, IMMUNE SYSTEM 
1ae6:H   (PRO149) to   (VAL211)  IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01  |   IMMUNOGLOBULIN, FAB FRAGMENT, HUMANISATION 
2av7:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.  |   TAX PEPTIDE, MHC, MUTATED HLA-A2, K66A., IMMUNE SYSTEM 
2av7:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.  |   TAX PEPTIDE, MHC, MUTATED HLA-A2, K66A., IMMUNE SYSTEM 
1agb:A   (GLU212) to   (TRP274)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1agd:A   (GLU212) to   (TRP274)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1age:A   (GLU212) to   (TRP274)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
3rtq:A   (PRO217) to   (TRP279)  STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
2axf:A   (GLU212) to   (TRP274)  THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION  |   IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX 
3rug:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)  |   MOUSE CD1D, MOUSE NKT, IMMUNE SYSTEM 
1akj:A   (GLU212) to   (ARG273)  COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8  |   T-CELL, GLYCOPROTEIN, SIGNAL, COMPLEX, IMMUNOLOGY, COMPLEX (MHC I/PEPTIDE/CD8) 
2b1h:H   (PRO151) to   (PRO227)  CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE  |   FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM 
3rzc:A   (PRO217) to   (TRP279)  STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
3ejy:E   (PRO157) to   (PRO220)  STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER, CLC-EC1  |   MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX 
1nsn:H   (PRO151) to   (LYS221)  THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN, STAPHYLOCOCCAL NUCLEASE, COMPLEX (IMMUNOGLOBULIN/HYDROLASE) COMPLEX 
1b0g:A   (GLU212) to   (TRP274)  CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX  |   CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN 
1b0g:D   (GLU212) to   (TRP274)  CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX  |   CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN 
4wu5:A   (GLU212) to   (TRP274)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)  |   IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I 
4wu5:D   (GLU212) to   (TRP274)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)  |   IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I 
4wu7:D   (GLU212) to   (TRP274)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F)  |   IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I 
1o0v:A   (ASP473) to   (VAL543)  THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION  |   IGE FC, IMMUNOGLOBULIN E, IMMUNE SYSTEM 
1o0v:B   (ASP473) to   (VAL543)  THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION  |   IGE FC, IMMUNOGLOBULIN E, IMMUNE SYSTEM 
2p5w:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY  |   T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM 
3eyq:D   (PRO161) to   (GLU224)  CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4hkj:A   (ASP212) to   (TRP274)  STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)  |   VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4hkj:E   (ASP212) to   (TRP274)  STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)  |   VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4hkj:I   (ASP212) to   (TRP274)  STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)  |   VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4hkj:M   (ASP212) to   (TRP274)  STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)  |   VIRAL IMMUNE EVASION PROTEINS, ANTIGEN PRESENTATION, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, INHIBITOR, INTRACELLULAR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3s4d:A   (GLY112) to   (GLU190)  LACTOSE PHOSPHORYLASE IN A TERNARY COMPLEX WITH CELLOBIOSE AND SULFATE  |   GH94, ALPHA BARREL, LACTOSE PHOSPHORYLASE, DISACCHARIDE PHOSPHORYLASE, TRANSFERASE 
1bii:A   (ASP212) to   (TRP274)  THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110  |   COMPLEX (MHC I/PEPTIDE), MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I DD, TRANSMEMBRANE, GLYCOPROTEIN 
1bln:B   (GLY169) to   (PRO227)  ANTI-P-GLYCOPROTEIN FAB MRK-16  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1bln:D   (GLY169) to   (PRO227)  ANTI-P-GLYCOPROTEIN FAB MRK-16  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
2bnq:A   (GLU212) to   (TRP274)  STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES  |   IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES 
3s62:H   (PRO151) to   (PRO214)  STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN  |   TYPICAL ANTIBODY FOLD, IMMUNE SYSTEM 
1bqh:A   (ASP212) to   (TRP274)  MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8  |   T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM 
3s7g:A   (PRO271) to   (LYS338)  AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT  |   AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN 
3s7g:B   (PRO271) to   (LYS338)  AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT  |   AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN 
3s7g:C   (PRO271) to   (LYS338)  AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT  |   AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN 
3s7g:D   (PRO271) to   (LYS338)  AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT  |   AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN 
2bsr:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705  |   IMMUNE SYSTEM/PEPTIDE, MHC, HLA-B27, HUMAN EBV, HIV, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, NUCLEAR PROTEIN, COMPLEX (ANTIGEN/PEPTIDE) 
2bst:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705  |   IMMUNE SYSTEM-PEPTIDE COMPLEX, MHC, HLA-B27, HUMAN EBV, HIV, FLU, GLYCOPROTEIN, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, COMPLEX (ANTIGEN/PEPTIDE), VIRAL NUCLEOPROTEIN 
4hqq:L   (GLY142) to   (ALA207)  CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4xbg:J   (PRO151) to   (PRO227)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
2bvo:A   (GLU212) to   (TRP274)  STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION  |   GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, SIGNAL, TRANSMEMBRANE, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID 
2bvp:A   (GLU212) to   (TRP274)  STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION  |   GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP, HIV-1, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, IMMUNE RESPONSE 
4hv8:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
3scm:A   (PRO217) to   (TYR278)  CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE  |   TERNARY COMPLEX, IMMUNITY, APC CELL SURFACE, IMMUNE SYSTEM 
4hwz:A   (ASP227) to   (TRP274)  STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV DERIVED PEPTIDE  |   HLA MOLECULES, PEPTIDE PRESENTATION, IMMUNE SYSTEM 
4hx1:A   (ASP227) to   (TRP274)  STRUCTURE OF HLA-A68 COMPLEXED WITH A TUMOR ANTIGEN DERIVED PEPTIDE  |   HLA MOLECULES, PEPTIDE PRESENTATION, IMMUNE SYSTEM 
3sdc:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE  |   CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, IMMUNE SYSTEM 
3ffc:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR  |   TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3ffc:F   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR  |   TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1oga:A   (GLU212) to   (TRP274)  A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.  |   IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR 
1ogt:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM/COMPLEX, IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705 
1c5b:H   (GLY169) to   (PRO227)  DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, DECARBOXYLASE, UNLIGANDED, IMMUNE SYSTEM 
4i2x:B   (GLY168) to   (PRO218)  CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117  |   PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM 
2pr4:H   (PRO168) to   (PRO232)  CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5  |   NMAB 2F5, GP41, HIV, VIRAL PROTEIN 
1cd1:A   (PRO217) to   (TYR278)  CD1(MOUSE) ANTIGEN PRESENTING MOLECULE  |   CD1, IMMUNOLOGY, MHC, TCR, GLYCOPROTEIN, SIGNAL, IMMUNOGLOBULIN FOLD, T-CELL 
1cd1:C   (PRO217) to   (TYR278)  CD1(MOUSE) ANTIGEN PRESENTING MOLECULE  |   CD1, IMMUNOLOGY, MHC, TCR, GLYCOPROTEIN, SIGNAL, IMMUNOGLOBULIN FOLD, T-CELL 
1ce6:A   (ASP212) to   (TRP274)  MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE  |   MHC CLASS I, ANTIGEN PRESENTATION, VIRAL PEPTIDE, COMPLEX 
4i4w:A   (ASP227) to   (ARG273)  PEPTIDE LENGTH DETERMINES THE OUTCOME OF T CELL RECEPTOR/PEPTIDE-MHCI ENGAGEMENT  |   MHC I FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, IMMUNE SYSTEM 
3sko:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE HLA-B8-A66-FLR, MUTANT A66 OF THE HLA B8  |   T CELL RECEPTOR, IMMUNE SYSTEM, ANTIGEN PRESENTATION 
1cfn:B   (GLY161) to   (PRO211)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
1cg9:A   (GLU212) to   (ARG273)  COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6  |   MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/ PEPTIDE), SFR8-B6 EPITOPE 
3fom:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE IQQSIERL  |   CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM 
3fon:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI  |   CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM 
3fon:C   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI  |   CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM 
1orq:B   (PRO154) to   (PRO217)  X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB  |   POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, KVAP, FAB COMPLEX, MEMBRANE PROTEIN 
3fqt:A   (ASP227) to   (TRP274)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
3fqu:A   (ASP227) to   (TRP274)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
1osz:A   (ASP212) to   (TRP274)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   MHC/PEPTIDE COMPLEX, TRANSMEMBRANE PROTEIN, THYMIC SELECTION, COMPLEX (MHC I/PEPTIDE) 
3fru:A   (GLU209) to   (LEU269)  NEONATAL FC RECEPTOR, PH 6.5  |   COMPLEX (IMMUNOGLOBULIN-BINDING PROTEIN), COMPLEX (IMMUNOGLOBULIN- BINDING PROTEIN) COMPLEX 
1cr9:H   (GLY159) to   (PRO209)  CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4  |   ANTI-PRION ANTIBODY, FAB 3F4, IMMUNE SYSTEM 
4icx:A    (LYS25) to    (LEU99)  N-TERMINAL C2 DOMAIN OF HUMAN CEP120  |   C2 DOMAIN, LIPID BINDING, TRANSPORT PROTEIN 
2c7u:A   (GLU212) to   (TRP274)  CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.  |   GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS 
2c7u:D   (GLU212) to   (TRP274)  CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.  |   GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS 
1ct8:D   (GLY162) to   (PRO212)  CATALYTIC ANTIBODY 7C8 COMPLEX  |   ABZYME TRANSITION STATE ANALOG, IMMUNE SYSTEM 
1cwp:A   (GLY103) to   (GLU176)  STRUCTURES OF THE NATIVE AND SWOLLEN FORMS OF COWPEA CHLOROTIC MOTTLE VIRUS DETERMINED BY X-RAY CRYSTALLOGRAPHY AND CRYO-ELECTRON MICROSCOPY  |   BROMOVIRUS, ICOSAHEDRAL VIRUS, VIRUS/RNA COMPLEX 
1cwp:B   (THR104) to   (GLU176)  STRUCTURES OF THE NATIVE AND SWOLLEN FORMS OF COWPEA CHLOROTIC MOTTLE VIRUS DETERMINED BY X-RAY CRYSTALLOGRAPHY AND CRYO-ELECTRON MICROSCOPY  |   BROMOVIRUS, ICOSAHEDRAL VIRUS, VIRUS/RNA COMPLEX 
1cwp:C   (THR104) to   (GLU166)  STRUCTURES OF THE NATIVE AND SWOLLEN FORMS OF COWPEA CHLOROTIC MOTTLE VIRUS DETERMINED BY X-RAY CRYSTALLOGRAPHY AND CRYO-ELECTRON MICROSCOPY  |   BROMOVIRUS, ICOSAHEDRAL VIRUS, VIRUS/RNA COMPLEX 
4xnz:B   (PRO156) to   (PRO220)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
2qad:C   (LYS145) to   (ARG211)  STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2qad:G   (LYS145) to   (ARG211)  STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xp1:H   (PRO155) to   (PRO218)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO NEUROTRANSMITTER DOPAMINE  |   INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX 
4xph:H   (GLY168) to   (PRO218)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO 3,4DICHLOROPHENETHYLAMINE  |   INTEGRAL MEMBRANE PROTEIN, NEUROTRANSMITTER TRANSPORTER, PROTEIN TRANSPORT-INHIBITOR COMPLEX 
1p7k:H   (GLY162) to   (PRO212)  CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)  |   FAB, ANTIBODY, ANTI-DNA ANTIBODY, AUTOANTIBODY, LUPUS, HEPES, IMMUNE SYSTEM 
1p7q:A   (GLU212) to   (ARG273)  CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR  |   HLA-A2/LIR-1 COMPLEX, IMMUNE SYSTEM 
1dbb:H   (PRO151) to   (PRO227)  THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX  |   IMMUNOGLOBULIN 
2cii:A   (ASP212) to   (TRP274)  THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY- INTERMEDIATE  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIGEN/PEPTIDE), MHC CLASS I, PEPTIDE BINDING, SENDAI VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, MEMBRANE, TRANSMEMBRANE 
2cik:A   (GLU212) to   (TRP274)  INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450.  |   IMMUNE SYSTEM/PEPTIDE, ANTIGEN/PEPTIDE COMPLEX, MAJOR HISTOCOMPATIBILITY ANTIGEN, HUMAN, MHC, HLA, HLA-B3501, EBV, ALLO-LIGAND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID 
2clr:A   (GLU212) to   (TRP274)  THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE  |   HISTOCOMPATIBILITY ANTIGEN 
2clr:D   (GLU212) to   (TRP274)  THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE  |   HISTOCOMPATIBILITY ANTIGEN 
2clz:A   (ASP212) to   (TRP274)  MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE  |   IMMUNE RESPONSE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN, TRANSMEMBRANE, ALLOREACTIVITY, MHC I, H-2KBM8, MEMBRANE, CLASS I MHC, POLYMORPHISM 
4iof:D   (ALA145) to   (ARG212)  CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)  |   HYDROLASE, ZINC METALLOPROTEASE 
3gbm:L   (GLY158) to   (PRO211)  CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.  |   HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX 
4irs:A   (PRO217) to   (TRP279)  STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
4xvu:C   (GLY171) to   (PRO222)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xwo:V   (ALA147) to   (ARG214)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xwo:X   (ALA147) to   (ASN213)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xxc:A   (GLU212) to   (TRP274)  HLA-B*1801 IN COMPLEX WITH A SELF-PEPTIDE, DELEIKAY  |   EBV, HLA, TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
2qrt:B   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C, BETA- 2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE.  |   MHC-I, OVA, SINGLE CHAIN MHC-I, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM 
3ghe:H   (PRO149) to   (LEU213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 537-10D IN COMPLEX WITH V3 PEPTIDE MN  |   HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM 
1duz:D   (GLU212) to   (TRP274)  HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3giv:A   (GLU212) to   (TRP274)  ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE  |   HIV, MHC, ESCAPE, ANTIGEN, IMMUNE RECOGNITION, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED', IMMUNE SYSTEM 
1psk:H   (PRO150) to   (LYS209)  THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE  |   FAB, GD2-GANGLIOSIDE, CARBOHYDRATE, MELANOMA, IMMUNOGLOBULIN 
2d31:D   (GLY207) to   (TRP274)  CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER  |   MHC CLASS I, IMMUNE SYSTEM/CELL CYCLE COMPLEX 
3gmm:A   (PRO217) to   (TRP279)  STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH  |   CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
3gmn:A   (PRO217) to   (TRP279)  STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH  |   CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
3gmp:A   (PRO217) to   (TRP279)  STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25  |   CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
3gmq:A   (PRO217) to   (TRP279)  STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED  |   CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
1e27:A   (GLU212) to   (TRP274)  NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI)  |   IMMUNE SYSTEM, HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1e28:A   (GLU212) to   (TRP274)  NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI)  |   HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
4y4f:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX  |   MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR 
2r0l:L   (LYS145) to   (ASN210)  SHORT FORM HGFA WITH INHIBITORY FAB75  |   SERINE PROTEASE, ANTIBODY, ALLOSTERIC INHIBITOR, EGF-LIKE DOMAIN, GLYCOPROTEIN, HYDROLASE, KRINGLE, SECRETED, ZYMOGEN, IMMUNE SYSTEM 
3tbs:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P,Y4A)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbs:D   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P,Y4A)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbv:C   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G,V3P,Y4A)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbw:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbw:C   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tby:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tby:D   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tby:G   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tby:J   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tcl:A   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04  |   IG, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2r4s:H   (GLY162) to   (PRO212)  CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR  |   TRANSMEMBRANE HELIX, G-PROTEIN COUPLED RECEPTOR, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, SIGNALING PROTEIN 
2r56:L   (ALA144) to   (ARG211)  CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN  |   ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM 
2r56:M   (ALA144) to   (ARG211)  CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN  |   ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM 
2r56:I   (PRO157) to   (PRO221)  CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN  |   ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM 
1e6o:H   (GLY169) to   (PRO219)  CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24  |   IMMUNOGLOBULIN, FAB, ANTIBODY, ANTIGEN, HIV-1, P24, CA 
1pzd:A   (VAL677) to   (VAL752)  STRUCTURAL IDENTIFICATION OF A CONSERVED APPENDAGE DOMAIN IN THE CARBOXYL-TERMINUS OF THE COPI GAMMA-SUBUNIT.  |   PLATFORM DOMAIN, APPENDAGE DOMAIN, EAR DOMAIN, ENDOCYTOSIS/EXOCYTOSIS COMPLEX 
3thm:H   (PRO168) to   (PRO232)  CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01  |   AGONISTIC ANTIBODY, FAB FRAGMENT, ANTIBODY-RECEPTOR COMPLEX, TUMOR NECROSIS FACTOR RECEPTOR, CYSTEINE-RICH DOMAIN, FAS, IMMUNE SYSTEM 
1ed3:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.  |   MAJOR HISTOCOMPATIBILITY COMPLEX, RAT MINOR HISTOCOMPATIBILITY COMPLEX, MHC, IMMUNOLOGY, PEPTIDE ANTIGEN PRESENTATION, CELLULAR IMMUNITY, CELL SURFACE RECEPTOR, T CELL RECEPTOR LIGAND, IMMUNE SYSTEM 
1ed3:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.  |   MAJOR HISTOCOMPATIBILITY COMPLEX, RAT MINOR HISTOCOMPATIBILITY COMPLEX, MHC, IMMUNOLOGY, PEPTIDE ANTIGEN PRESENTATION, CELLULAR IMMUNITY, CELL SURFACE RECEPTOR, T CELL RECEPTOR LIGAND, IMMUNE SYSTEM 
4jdv:A   (GLY166) to   (PRO217)  CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB  |   IG FOLD, ANTI HIV ANTIBODY, IMMUNE SYSTEM 
1eey:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)  |   MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM 
1eey:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)  |   MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM 
1eez:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM 
1q9o:D   (GLY160) to   (PRO210)  S45-18 FAB UNLIGANDED  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1efx:A   (ILE213) to   (TRP274)  STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3  |   MHC, HLA, CLASS I, KIR, NK CELL RECEPTOR, IMMUNOGLOBULIN FOLD, RECEPTOR/MHC COMPLEX, IMMUNE SYSTEM 
4jfo:A   (GLU212) to   (TRP274)  A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
4jfo:D   (ILE213) to   (TRP274)  A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
4jfq:A   (GLU212) to   (TRP274)  A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
2dtm:L   (ASN145) to   (ASN210)  THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1qew:A   (GLU212) to   (TRP274)  HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)  |   COMPLEX (MHC PROTEINTIGEN), HISTOCOMPATIBILITY ANTIGEN 
4yfl:I   (VAL144) to   (PRO208)  CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 1B2530 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120  |   HIV-1 CD4 BINDING SITE, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
1qlf:A   (ASP212) to   (TRP274)  MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G  |   IMMUNE SYSTEM/PEPTIDE, MURINE CLASS I MHC/PEPTIDE COMPLEX, MHC, GLYCOPEPTIDE, ANTIGEN, HISTOCOMPATIBILITY, IMMUNOLOGY 
3tv3:H   (PRO151) to   (PRO227)  CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9  |   FAB, HIV-1 NEUTRALIZING ANTIBODY, GP120, IMMUNE SYSTEM 
1qo3:A   (ASP212) to   (TRP274)  COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD  |   RECEPTOR/IMMUNE SYSTEM, COMPLEX (NK RECEPTOR/MHC CLASS I), NK CELL, INHIBITORY RECEPTOR, MHC-I, C-TYPE LECTIN-LIKE, HISTOCOMPATIBILITY, B2M, LY49, LY-49 
4jpi:A   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB  |   ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
4jqv:A   (GLU212) to   (TRP274)  HLA-B*18:01 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 173-180)  |   IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM 
4jqx:A   (GLU212) to   (TRP274)  HLA-B*44:03 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 169-180)  |   IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM 
4jry:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX  |   TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM 
3tyg:H   (VAL152) to   (LYS228)  CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3)  |   GP120, HIV-1, ENV, FAB, HIV-1 NEUTRALIZING ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN 
1qse:A   (GLU212) to   (TRP274)  STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R  |   HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM 
1qvo:A   (ILE213) to   (TRP274)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
1qvo:D   (GLU212) to   (TRP274)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
3h9h:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3h9h:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3h9s:A   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3h9y:A   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3h9y:B   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3h9y:E   (VAL370) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3h9y:E   (ASP473) to   (ASN544)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:A   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:B   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:C   (LYS367) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1f6a:D   (VAL370) to   (LYS435)  STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)  |   IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, RECEPTOR, IGE-BINDING PROTEIN, IGE ANTIBODY, IGE-FC, IMMUNE SYSTEM 
4jvu:A   (PRO266) to   (SER335)  IGM C2-DOMAIN FROM MOUSE  |   IMMUNOGLOBULIN M, ANTIBODY, OLIGOMERIZATION, IMMUNOGLOBULIN FOLD, RECEPTOR, PROTEIN BINDING 
3hcv:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA-B*2709, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, DISULFIDE BOND, MHC I 
4jy4:A   (ALA144) to   (ALA208)  CRYSTAL STRUCTURE OF HUMAN FAB PGT121, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   BROADLY NEUTRALIZING ANTIBODY AGAINST HIV-1, HIV-1 ENV GP120 SUBUNIT, IMMUNE SYSTEM 
4jy6:B   (PRO147) to   (PRO211)  CRYSTAL STRUCTURE OF HUMAN FAB PGT123, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   BROADLY NEUTRALIZING ANTIBODY AGAINST HIV-1, HIV-1 ENV GP120 SUBUNIT, IMMUNE SYSTEM 
4jy6:C   (THR146) to   (ALA208)  CRYSTAL STRUCTURE OF HUMAN FAB PGT123, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   BROADLY NEUTRALIZING ANTIBODY AGAINST HIV-1, HIV-1 ENV GP120 SUBUNIT, IMMUNE SYSTEM 
1ffp:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX 
1ffp:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX 
1fh5:H   (PRO151) to   (PRO214)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33  |   FAB, BIP, IMMUNE SYSTEM 
4ypg:B   (GLY165) to   (PRO216)  STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY  |   THERAPEUTIC MAB, IFN-ALPHA2A 
2v2x:A   (GLU212) to   (TRP274)  T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.  |   IMMUNE SYSTEM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, MHC TCR HLA-A2 HIV, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID 
2v2x:D   (GLU212) to   (TRP274)  T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.  |   IMMUNE SYSTEM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, MHC TCR HLA-A2 HIV, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID 
1fj1:B   (GLU148) to   (SER213)  LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2  |   OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM 
4yr6:D   (PRO158) to   (ALA221)  FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE  |   GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM 
1fo0:H   (ASP212) to   (TRP274)  MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX  |   T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, IMMUNE SYSTEM 
2exw:E   (PRO157) to   (PRO220)  CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS  |   CLC FAMILY OF CL- CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
4k7f:D   (GLU212) to   (TRP274)  NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201  |   HOST-VIRUS INTERACTION, IMMUNE RESPONSE, DISEASE MUTATION, VIRAL REPLICATION, IG-LIKE DOMAIN, IMMUNE SYSTEM, TCR, MEMBRANE GLYCOPROTEIN, VIRAL CAPSID PROTEIN 
1rhh:D   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION  |   FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM 
2vaa:A   (ASP212) to   (TRP274)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, MHC-PEPTIDE COMPLEX, COMPLEX (MHC I/PEPTIDE) COMPLEX 
2vab:A   (ASP212) to   (TRP274)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN  |   HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, MHC-PEPTIDE COMPLEX, COMPLEX (MHC I/PEPTIDE) COMPLEX 
1rjz:A   (ASP212) to   (TRP274)  MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE  |   MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM 
1rjz:D   (ASP212) to   (TRP274)  MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE  |   MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM 
1rk1:A   (ASP212) to   (TRP274)  MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE  |   MHC, CLASS I, VIRUS, TCR, HERPES, IMMUNE SYSTEM 
3ulu:L   (LYS145) to   (ASN210)  STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)  |   TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2f53:A   (GLU212) to   (TRP274)  DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY  |   T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM 
2f54:F   (GLU212) to   (TRP274)  DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY  |   T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, WILD TYPE SEQUENCE, HIGH AFFINITY, NY-ESO-1, IMMUNE SYSTEM 
2f5a:H   (PRO168) to   (PRO232)  CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5  |   FAB, HIV-1 NEUTRALIZATION, GP41, IMMUNOGLOBULIN 
2f74:A   (ASP212) to   (TRP274)  MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM 
2f74:D   (ASP212) to   (ARG273)  MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM 
1fzj:A   (ASP212) to   (TRP274)  MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
1fzk:A   (ASP212) to   (TRP274)  MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
1fzm:A   (ASP212) to   (TRP274)  MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
2fat:H   (PRO144) to   (ALA207)  AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE  |   ANTI-UPAR ANTIBODY, ATN-615, FAB, CRYSTAL STRUCTURE, IMMUNE SYSTEM 
2fec:L   (ASN144) to   (ALA211)  STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2fee:I   (PRO157) to   (PRO220)  STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2fed:E   (GLY170) to   (PRO220)  STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2ve6:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE  |   PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED 
2ve6:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE  |   PHOTOCLEAVABLE PEPTIDE, AUXILIARY ANCHORING RESIDUE, GLYCOPROTEIN, TRANSMEMBRANE, PEPTIDE LOADING, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, MHC, SEV9, MHC I, MEMBRANE, SECRETED 
1g7p:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE  |   MHC CLASS I, H-2KB, YEAST, S. CEREVISIAE, ALPHA-GLUCOSIDASE, IMMUNE SYSTEM 
1g7q:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA  |   MHC CLASS I, H-2KB, MUC1, VNTR, MUCIN, IMMUNE SYSTEM 
1rzf:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rzi:C   (ALA144) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
3hpj:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE  |   WT-1, WT1, WT126 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3hpj:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE  |   WT-1, WT1, WT126 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
4z5r:A   (LYS145) to   (ARG211)  RONTALIZUMAB FAB BOUND TO INTERFERON-A2  |   ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX 
2vit:B   (PRO158) to   (PRO221)  INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (HEMAGGLUTININ/IMMMUNOGLOBULIN), GLYCOPROTEIN 
4kkb:E   (GLY170) to   (PRO220)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4z76:A   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
4z76:D   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
4z77:A   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
4z78:A   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
4z78:D   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
4z78:G   (ASP212) to   (TRP274)  WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES  |   IMMUNOGLOBULIN, H-2KD, TYPE 1 DIABETES, IMMUNE SYSTEM 
2vjx:B   (LYS722) to   (ARG777)  STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES  |   LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE 
4z8f:H   (SER149) to   (LYS209)  FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-P5(DT)P- 3'  |   ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM-DNA COMPLEX 
4z95:H   (SER149) to   (PRO212)  FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-5(DT)-P- 3'  |   ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM, IMMUNE SYSTEM-DNA COMPLEX 
4z95:L   (ILE144) to   (ASN210)  FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-5(DT)-P- 3'  |   ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM, IMMUNE SYSTEM-DNA COMPLEX 
2fo4:A   (ASP212) to   (TRP274)  ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE  |   ANCHOR MODIFICATIONS, H-2KB, MUC1, NON-CANONICAL PEPTIDE, MUC1-8, VACCINE DESIGN, IMMUNE SYSTEM 
4zak:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX  |   MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM 
1s7q:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7t:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7u:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7u:G   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7u:J   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7w:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7w:G   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7x:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7x:D   (ASP212) to   (ARG273)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7x:G   (ASP212) to   (ARG273)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7x:J   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s8d:A   (ASP227) to   (TRP274)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE- MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1s9w:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2  |   IMMUNE SYSTEM 
1s9x:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2  |   IMMUNE SYSTEM 
1s9y:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2  |   IMMUNE SYSTEM 
1sbs:L   (ASN151) to   (ASN216)  CRYSTAL STRUCTURE OF AN ANTI-HCG FAB  |   MONOCLONAL ANTIBODY, FAB-FRAGMENT, REPRODUCTION 
2vl4:A   (LYS722) to   (ARG777)  STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES  |   LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE 
2vl4:B   (ILE723) to   (ARG777)  STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES  |   LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE 
1seq:H   (GLY162) to   (PRO212)  FAB MNAC13  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
2vlj:A   (GLU212) to   (TRP274)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX 
2vll:A   (GLU212) to   (TRP274)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX 
2vll:D   (GLU212) to   (TRP274)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX 
3v5d:A   (GLU212) to   (TRP274)  HLA-A2.1 KVAELVHFL  |   PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM 
3v5d:D   (GLU212) to   (TRP274)  HLA-A2.1 KVAELVHFL  |   PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM 
3v5k:D   (GLU212) to   (TRP274)  HLA2.1 KVAELVWFL  |   PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM 
3hzm:B   (GLY161) to   (PRO211)  CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
2fyy:A   (GLU212) to   (TRP274)  THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION  |   MHC, HLA-B*3501, IG DOMAIN, IMMUNE SYSTEM 
2fz3:A   (GLU212) to   (TRP274)  THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION  |   MHC, HLA-B*3508, IG DOMAIN, IMMUNE SYSTEM 
3i02:D   (PRO149) to   (ILE210)  CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
2vq1:F   (PRO149) to   (ARG209)  ANTI TRIMERIC LEWIS X FAB54-5C10-A  |   MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM 
3v95:B   (ASP270) to   (LYS338)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
2vqu:A   (ILE723) to   (ARG777)  STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES  |   LINEAR FREE ENERGY RELATIONSHIP, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE, HYDROLASE 
2vqt:A   (LYS722) to   (ARG777)  STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES  |   LINEAR FREE ENERGY RELATIONSHIP, TRANSITION STATE MIMIC, HYDROLASE, MANNOSIDASE, GLYCOSIDE HYDROLASE 
2vqt:B   (LYS722) to   (ARG777)  STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES  |   LINEAR FREE ENERGY RELATIONSHIP, TRANSITION STATE MIMIC, HYDROLASE, MANNOSIDASE, GLYCOSIDE HYDROLASE 
4kuc:H   (PRO176) to   (PRO237)  CRYSTAL STRUCTURE OF RICIN-A CHAIN IN COMPLEX WITH THE ANTIBODY 6C2  |   RNA-N-GLYCOSIDASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3vcl:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B7 WITH THE HCMV PP65 PEPTIDE RPHERNGFTVL  |   CLASS I HISTOCOMPATIBILITY ANTIGEN, ANTIGEN PRESENTATION, T-CELL RECEPTOR, MEMBRANE, IMMUNE SYSTEM 
4kvn:H   (PRO161) to   (LYS222)  CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)  |   IGG, ANTIBODY, IMMUNE SYSTEM 
3i6g:A   (GLU212) to   (TRP274)  NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3i6g:D   (GLU212) to   (TRP274)  NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3i6k:A   (GLU212) to   (TRP274)  NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3i6k:E   (GLU212) to   (TRP274)  NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
1sys:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY  |   HLA, MHC, CLASS I, B44, IMMUNE SYSTEM 
1syv:A   (GLU212) to   (TRP274)  HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF  |   HLA, MHC, CLASS I, B44, IMMUNE SYSTEM 
3vfm:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP155A, HLA MUTANT ALA155  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfn:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508LPEP151A, HLA MUTANT ALA151  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfo:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP157A, HLA MUTANT ALA157  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfp:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP158G, HLA MUTANT GLY158  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfr:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508LPEP-P4ALA, PEPTIDE MUTANT P4-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfs:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508LPEP-P5ALA , PEPTIDE MUTANT P5-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vft:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508LPEP-P6ALA, PEPTIDE MUTANT P6-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfu:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P7ALA, PEPTIDE MUTANT P7-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfv:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P9ALA, PEPTIDE MUTANT P9-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfw:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P10ALA, PEPTIDE MUTANT P10-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
1t04:B   (PRO153) to   (PRO217)  THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP  |   ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, X-RAY STRUCTURE, THREE-DIMENSIONAL STRUCTURE, GAMMA- INTERFERON, IMMUNE SYSTEM 
3vh8:A   (GLU212) to   (TRP274)  KIR3DL1 IN COMPLEX WITH HLA-B*5701  |   IMMUNOGLOBULIN FOLD, NATURAL KILLER CELL RECEPTOR, IMMUNE SYSTEM 
1t1w:A   (ASP227) to   (TRP274)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1t1x:A   (ASP227) to   (TRP274)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1t1z:A   (ASP227) to   (TRP274)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1t20:A   (ASP227) to   (TRP274)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1t21:A   (ASP227) to   (TRP274)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
2git:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE  |   HTLV-1 TAX PEPTIDE, HAPTENATED PEPTIDE, LYSINE-4-(3-INDOLYL)-BUTYRIC ACID, MHC CLASS I,HLA-A2, IMMUNE SYSTEM 
3vj6:A   (ASP212) to   (TRP274)  STRUCTURE OF THE MHC CLASS IB MOLECULE QA-1B  |   MHC-CLASSIB, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, PEPTIDE PRESENTATION, CD94-NKG2A/C RECEPTORS 
4l5f:H   (GLY162) to   (SER212)  CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII  |   ANTIBODY, FAB, NEUTRALIZING, VIRUS, ENVELOPE, VIRAL PROTEIN, IMMUNE SYSTEM, ANTIBODY EPITOPE, INFECTIOUS DISEASE, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID), NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 
1t66:D   (GLY167) to   (PRO217)  THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.  |   ANTIBODY, FAB, FLUORESCEIN, IMMUNE SYSTEM 
4l8c:C   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE  |   INFLUENZA, VIRAL ESCAPE, T CELL IMMUNITY, IMMUNE SYSTEM 
2gsi:B   (PRO151) to   (PRO227)  CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE  |   FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM 
3ijh:B   (PRO149) to   (ARG209)  STRUCTURE OF S67-27 IN COMPLEX WITH KO  |   ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM 
3ijh:C   (ASN144) to   (ASN211)  STRUCTURE OF S67-27 IN COMPLEX WITH KO  |   ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM 
3ijs:A   (ASN144) to   (ASN209)  STRUCTURE OF S67-27 IN COMPLEX WITH TSBP  |   ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM 
3ijy:C   (ASN144) to   (ASN209)  STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO  |   ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM 
3ijy:D   (PRO149) to   (PRO212)  STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO  |   ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM 
2gtz:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A28L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
2guo:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
4lcy:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION  |   ANTIGEN PRESENTING, CELL SURFACE, HLA-B46, MEMBRANE PROTEIN 
4lf3:B   (PRO378) to   (PRO442)  INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR  |   FAB FRAGMENT, GCGR, IMMUNE SYSTEM 
4lf3:E   (PRO378) to   (GLU441)  INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR  |   FAB FRAGMENT, GCGR, IMMUNE SYSTEM 
4zus:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE REV-QW11  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
4zuv:A   (ILE213) to   (TRP274)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
4zuv:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
2h1p:H   (PRO456) to   (PRO519)  THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES  |   ANTIBODY STRUCTURE, CRYPTOCOCCUS, PEPTIDE, PHAGE LIBRARY, POLYSACCHARIDE, COMPLEX (ANTIBODY/PEPTIDE) 
1tjh:H   (GLY162) to   (PRO213)  CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE  |   2F5, ANTIBODY, GP41, HIV-1, NEUTRALIZING, MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1hh6:B   (GLY161) to   (PRO211)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE  |   ANTIBODY/PEPTIDE, POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1, IMMUNE SYSTEM 
1hhg:A   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhg:D   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
2h2p:E   (GLY170) to   (PRO220)  CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-  |   CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT 
1hhh:A   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhi:A   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhi:D   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhj:D   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhk:A   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhk:D   (GLU212) to   (TRP274)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
2h6p:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE, KPIVVLHGY  |   IMMUNE SYSTEM, GENE REGULATION 
3ixa:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE  |   TEL1P, TAX, A150P MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
4lkx:A   (PRO149) to   (PRO213)  HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT  |   IMMUNOGLOBULIN, ANTIBODY, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
2hh0:H   (PRO192) to   (PRO271)  STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.  |   PRION, PRP, FAB, IMMUNE SYSTEM 
1tvb:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2  |   MELANOMA; X-RAY; GP100; PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM 
1tvh:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2  |   MELANOMA; X-RAY; MODIFIED GP100 PEPTIDE; GP100(209-T2M) PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM 
3vri:A   (GLU212) to   (TRP274)  HLA-B*57:01-RVAQLENVYI IN COMPLEX WITH ABACAVIR  |   HUMAN LEUKOCYTE ANTIGEN, ANTIGEN PRESENTATION, IMMUNE SYSTEM, T-CELL RECEPTOR 
3vrj:A   (GLU212) to   (TRP274)  HLA-B*57:01-LTTKLTNTNI IN COMPLEX WITH ABACAVIR  |   HUMAN LEUKOCYTE ANTIGEN, ANTIGEN PRESENTATION, IMMUNE SYSTEM, T-CELL RECEPTOR 
2hjk:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE  |   B57, HLA, HIV, IMMUNE SYSTEM 
4lnr:A   (GLU212) to   (TRP274)  THE STRUCTURE OF HLA-B*35:01 IN COMPLEX WITH THE PEPTIDE (RPQVPLRPMTY)  |   HETEROTRIMER, LIGAND FOR T CELL RECEPTOR, IMMUNE SYSTEM 
2hn7:A   (ASP227) to   (TRP274)  HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE  |   PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, HEPATITIS B VIRUS, HBV, IMMUNE SYSTEM 
1hzh:H   (GLU285) to   (LYS358)  CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN  |   IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM 
1i1a:A   (GLU209) to   (LEU269)  CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC  |   MHC CLASS I FOLD, IG CONSTANT DOMAINS, IMMUNE SYSTEM 
1i1a:C   (ARG274) to   (LYS338)  CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC  |   MHC CLASS I FOLD, IG CONSTANT DOMAINS, IMMUNE SYSTEM 
1i1y:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y  |   HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM 
3vxm:A   (ASP227) to   (TRP274)  THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxp:A   (ASP227) to   (TRP274)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE 
3vxp:D   (GLU212) to   (TRP274)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE 
3vxu:A   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxu:F   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
2hrp:M   (ASP143) to   (ASN212)  ANTIGEN-ANTIBODY COMPLEX  |   FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, COMPLEX (IMMUNOGLOBULIN/PEPTIDE) 
4lsp:H   (GLY162) to   (PRO213)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057  |   NEUTRALIZING ANTIBODY VRC-CH31, HIV ENVELOPE GLYCOPROTEIN GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1i4f:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, MELANOMA-ASSOCIATED ANTIGEN, IMMUNE SYSTEM 
2ht2:E   (GLY170) to   (PRO220)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2ht3:C   (GLY170) to   (PRO220)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2ht3:E   (GLY170) to   (PRO220)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
1i7r:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058  |   MHC FOLD, IMMUNE SYSTEM 
1i7r:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058  |   MHC FOLD, IMMUNE SYSTEM 
1i7t:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V  |   MHC FOLD, IMMUNE SYSTEM 
1i7t:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V  |   MHC FOLD, IMMUNE SYSTEM 
1i7z:B   (PRO151) to   (PRO225)  ANTIBODY GNC92H2 BOUND TO LIGAND  |   IGG FOLD, ANTIBODY, CHIMERA, IMMUNE SYSTEM 
1il1:A   (PRO157) to   (PRO220)  CRYSTAL STRUCTURE OF G3-519, AN ANTI-HIV MONOCLONAL ANTIBODY  |   FAB, BETA SHEET STRUCTURE, ANTIBODY, IMMUNE SYSTEM 
1im9:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4  |   PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN DOMAIN, ANTIPARALLEL BETA SHEET, ALPHA HELIX, IMMUNE SYSTEM 
2i9l:D   (GLY168) to   (PRO218)  STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN  |   NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
2i9l:H   (GLY168) to   (PRO218)  STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN  |   NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
4m43:H   (GLY169) to   (PRO227)  CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4m7l:L   (ALA150) to   (ASN216)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT  |   ANTIBODY, BLOOD CLOTTING-IMMUNE SYSTEM COMPLEX 
1uqs:A   (VAL216) to   (GLY280)  THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID  |   GLYCOPROTEIN, LIPID, GMM, CD1B, MHC, ANTIGEN PRESENTATION 
2ig2:L   (ALA145) to   (PRO210)  DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)  |   IMMUNOGLOBULIN 
3j2x:A   (ASN149) to   (ASN214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j2x:B   (PRO653) to   (PRO716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j2x:C  (ASN1149) to  (ASN1214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j2x:D  (PRO1653) to  (PRO1716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j2x:E  (ASN2149) to  (ASN2214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j2x:F  (PRO2653) to  (PRO2716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j2x:G  (ASN3149) to  (ASN3214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j2x:H  (PRO3653) to  (PRO3716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M242, IMMUNE SYSTEM 
3j30:A   (ASN149) to   (ASN214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
3j30:B   (PRO653) to   (PRO716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
3j30:C  (ASN1149) to  (ASN1214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
3j30:D  (PRO1653) to  (PRO1716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
3j30:E  (ASN2149) to  (ASN2214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
3j30:F  (PRO2653) to  (PRO2716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
3j30:G  (ASN3149) to  (ASN3214)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
3j30:H  (PRO3653) to  (PRO3716)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY CHK152, IMMUNE SYSTEM 
1uxs:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (HLA/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705, EPSTEIN-BARR VIRUS, 
2x4o:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION 
2x4o:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION 
2x4p:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1) 
2x4p:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1) 
2x4q:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION, PHOTOCLEAVABLE PEPTIDE 
2x4r:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE  |   IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM 
2x4r:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE  |   IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM 
2x4s:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN  |   PHOTOCLEAVABLE PEPTIDE, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1) 
2x4s:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN  |   PHOTOCLEAVABLE PEPTIDE, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1) 
2x4t:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE  |   MHC CLASS I, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM 
2x4t:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE  |   MHC CLASS I, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, IMMUNE RESPONSE, IMMUNE SYSTEM 
2x4u:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION 
2ipu:K   (ASN144) to   (ASN209)  PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE  |   WWDDD, CDR, ABETA, IMMUNE SYSTEM 
2ipu:G   (PRO149) to   (PRO212)  PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE  |   WWDDD, CDR, ABETA, IMMUNE SYSTEM 
3wkm:H   (GLY172) to   (PRO222)  THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT  |   PDZ DOMAIN, HYDROLASE 
3wkn:B   (PRO271) to   (SER337)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wkn:M   (PRO271) to   (LYS338)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
2x70:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION 
3wl9:A   (GLU212) to   (TRP274)  HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8I10F)  |   HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR 
3wlb:A   (GLU212) to   (TRP274)  HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8T10F)  |   HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR 
4mj5:A   (ASP227) to   (TRP274)  HLA-A11 COMPLEXED WITH A PEPITDE  |   MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX 
4mj6:A   (GLU212) to   (TRP274)  HLA-A11 COMPLEXED WITH A MUTATED PEPTIDE  |   MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX 
5alc:H   (PRO149) to   (PRO213)  TICAGRELOR ANTIDOTE CANDIDATE FAB 72 IN COMPLEX WITH TICAGRELOR  |   IMMUNE SYSTEM, ANTIBODY FRAGMENT, ANTIDOTE, DRUG 
1v7m:I   (PRO152) to   (VAL214)  HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX 
3wn5:B   (LYS274) to   (LYS338)  CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
5anm:F   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA 
5anm:G   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA 
5any:I   (GLY162) to   (SER212)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265  |   VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB 
5any:J   (GLY162) to   (SER212)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265  |   VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB 
5any:K   (GLY162) to   (SER212)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265  |   VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB 
5any:L   (GLY162) to   (SER212)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265  |   VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB 
1jgd:A   (GLU212) to   (TRP274)  HLA-B*2709 BOUND TO DECA-PEPTIDE S10R  |   MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM 
1jge:A   (ILE213) to   (TRP274)  HLA-B*2705 BOUND TO NONA-PEPTIDE M9  |   MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM 
1jht:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART- 1/MELAN-A.  |   HUMAN, TUMOR IMMUNITY, MELANOMA ANTIGEN, MHC, VACCINATION, MELANOMA, CLASS I, IMMUNE SYSTEM 
3ws3:A   (ASP236) to   (TRP298)  CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE  |   CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, INSULIN, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM 
3ws3:C   (ASP236) to   (TRP298)  CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE  |   CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, INSULIN, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM 
3ws6:B   (ASP236) to   (TRP298)  CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE  |   CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, MIMOTOPE, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM 
1jn6:A   (GLY161) to   (SER210)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
1jn6:B   (PRO154) to   (PRO217)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
1jnh:H   (PRO154) to   (PRO217)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
1jnl:H   (PRO152) to   (LYS222)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
1jpt:H   (PRO153) to   (PRO217)  CRYSTAL STRUCTURE OF FAB D3H44  |   ANTIGEN-ANTIBODY RECOGNITION, HUMANIZED ANTIBODY, BLOOD COAGULATION, CRYSTAL STRUCTURE, IMMUNE SYSTEM 
1vpo:L   (ILE149) to   (ASP217)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE  |   FAB FRAGMENT, ANTI-STEROID, TESTOSTERONE COMPLEX, IMMUNE SYSTEM 
2j8u:A   (GLU212) to   (TRP274)  LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL 
2j8u:H   (GLU212) to   (TRP274)  LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL 
5awn:H   (PRO149) to   (GLU212)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB  |   HIV-1, ENV, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
1w0v:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1  |   IMMUNE SYSTEM, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2705, MHC I 
1w0w:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1  |   IMMUNE SYSTEM, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2705, MHC I 
4n0f:A   (GLU207) to   (LEU267)  HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN  |   ALPHA/BETA, RECEPTOR, IGG CONSTANT DOMAIN, MEMBRANE, IMMUNE SYSTEM 
3x11:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*57:01.I80N.L82R.R83G  |   IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS LILRS, TCRS, KIRS, PLASMA MEMBRANE, IMMUNE SYSTEM 
3x12:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*57:01.I80N  |   IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM 
3x13:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*0801.N80I  |   IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM 
3x14:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*0801.N80I.R82L.G83R  |   IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM 
2xpg:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX  |   IMMUNE SYSTEM, AUTOIMMUNITY, MULTIPLE SCLEROSIS 
2jb5:L   (ALA148) to   (PRO213)  FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1  |   CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM 
2jcc:A   (GLU212) to   (TRP274)  AH3 RECOGNITION OF MUTANT HLA-A2 W167A  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN 
2jcc:H   (GLU212) to   (TRP274)  AH3 RECOGNITION OF MUTANT HLA-A2 W167A  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN 
5b38:A   (GLU212) to   (TRP274)  KIR3DL1*005 IN COMPLEX WITH HLA-B*57:01  |   INNATE IMMUNE RECEPTOR, KIR, NATURAL KILLER CELL, IMMUNE SYSTEM 
5b39:A   (GLU212) to   (TRP274)  KIR3DL1*015 IN COMPLEX WITH HLA-B*57:01  |   INNATE IMMUNE RECEPTOR, KIR, NATURAL KILLER CELL, IMMUNE SYSTEM 
1w72:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3  |   IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I 
4n8v:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A  |   ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM 
4n8v:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A  |   ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM 
5bq7:A   (PRO154) to   (PRO218)  CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT  |   HUMAN ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
5bs0:A   (ASP227) to   (TRP274)  MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1  |   IMMUNO PMHC TCR TITIN, IMMUNE SYSTEM 
4ncc:H   (PRO155) to   (PRO218)  NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS  |   IMMUNOGLOBIN, ANTIBODY, MURINE NOROVIRUS, IMMUNE SYSTEM 
4ncc:2   (PRO155) to   (PRO218)  NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS  |   IMMUNOGLOBIN, ANTIBODY, MURINE NOROVIRUS, IMMUNE SYSTEM 
1wbx:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE  |   MHC CLASS I, INFLUENZA PEPTIDE, HA468, IMMUNE SYSTEM 
2xzc:H   (PRO155) to   (PRO219)  CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM 
2xzq:H   (PRO156) to   (PRO219)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF  |   BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN, IMMUNE SYSTEM 
1k8d:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE  |   CRYSTAL STRUCTURE, NON-CLASSICAL MHC CLASS I, ANTIGEN PRESENTATION, PREIMPLANTATION EMBRYO DEVOLEPMENT GENE PRODUCT, QA-2, Q9, IMMUNE SYSTEM 
5bxf:C   (GLU207) to   (LEU267)  APO FCRN STRUCTURE AT PH 4.5  |   FCRN, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
1kbg:H   (ASP212) to   (TRP274)  MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2  |   MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, ANTIGEN PRESENTATION, GLYCOPEPTIDE, CELLULAR IMMUNITY, IMMUNOLOGY, CELL SURFACE RECEPTOR, SYNTHETIC PEPTIDE, VACCINE, IMMUNE SYSTEM 
1kcr:H   (PRO152) to   (PRO215)  CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE  |   ANTIBODY, PEPTIDE ANTIGEN COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM 
4nj9:L   (ASN145) to   (ASN210)  CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS  |   IMMUNOGLOBULIN FOLD, MPTS, IMMUNE SYSTEM 
5c07:A   (GLU212) to   (TRP274)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0e:A   (ASP227) to   (TRP274)  HLA-A02 CARRYING YLGGPDFPTI  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0f:A   (ASP227) to   (TRP274)  HLA-A02 CARRYING RQWGPDPAAV  |   IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM 
5c0h:A   (ASP227) to   (TRP274)  HLA-A02 CARRYING MVWGPDPLYV  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-RTEACTIVITY, IMMUNE SYSTEM 
5c0i:A   (ASP227) to   (TRP274)  HAL-A02 CARRYING RQFGPDFPTI  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0j:A   (ASP227) to   (TRP274)  HLA-A02 CARRYING RQFGPDWIVA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
1kj2:I   (ASP212) to   (TRP274)  MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX  |   T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, ALLOGENEIC, IMMUNE SYSTEM 
4no0:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1  |   NONPHOSPHORYLATED PEPTIDE, PEPTIDE-MHC COMPLEX, MHC, LILRB1, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX 
3jbq:L   (ILE144) to   (ASN210)  DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6  |   PHOSPHODIESTERASE, PHOTORECEPTOR, PDE6, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3jbq:l   (ILE144) to   (ASN210)  DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6  |   PHOSPHODIESTERASE, PHOTORECEPTOR, PDE6, HYDROLASE-IMMUNE SYSTEM COMPLEX 
1kjv:A   (ASP212) to   (TRP274)  TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE  |   PEPTIDE-MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE SYSTEM 
2ltq:F   (PRO155) to   (LYS215)  HIGH RESOLUTION STRUCTURE OF DSBB C41S BY JOINT CALCULATION WITH SOLID-STATE NMR AND X-RAY DATA  |   MEMBRANE PROTEIN, OXIDOREDUCTASE, DISULFIDE BOND, REDOX-ACTIVE CENTER, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, TRANSMEMBRANE, TRANSPORT 
4nqs:A   (PRO271) to   (LYS338)  KNOB-INTO-HOLE IGG FC  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4nqs:B   (PRO271) to   (LYS338)  KNOB-INTO-HOLE IGG FC  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4nqs:G   (ASP270) to   (LYS338)  KNOB-INTO-HOLE IGG FC  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4nqs:H   (ASP270) to   (LYS338)  KNOB-INTO-HOLE IGG FC  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4nqt:A   (PRO271) to   (SER337)  ANTI-PARALLEL FC-HOLE(T366S/L368A/Y407V) HOMODIMER  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4nqv:G   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqx:K   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nrz:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6  |   IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM 
4nsk:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND V3P  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-PEPTIDE COMPLEX 
1kpr:A   (GLU212) to   (TRP274)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM 
1kpr:C   (GLU212) to   (TRP274)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM 
1kpu:A   (ASP212) to   (TRP274)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/VSV8  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE-MHC, IMMUNE SYSTEM 
1x7q:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE  |   PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, SARS, IMMUNE SYSTEM 
4nzr:H   (PRO151) to   (PRO227)  CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB  |   LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, IMMUNE SYSTEM-PROTEIN BINDING COMPLEX 
1xf4:A   (ILE144) to   (ASN212)  STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING  |   ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM 
4o2c:A   (GLU212) to   (TRP274)  AN NT-ACETYLATED PEPTIDE COMPLEXED WITH HLA-B*3901  |   IG-LIKE, IMMUNE SYSTEM 
4o2e:D   (GLU212) to   (TRP274)  A PEPTIDE COMPLEXED WITH HLA-B*3901  |   IG-LIKE, IMMUNE SYSTEM 
4o2f:A   (GLU212) to   (TRP274)  A PEPTIDE COMPLEXED WITH HLA-B*3901  |   IG-LIKE, IMMUNE SYSTEM 
4o58:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ  |   IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5cd3:G   (PRO148) to   (PRO212)  STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7  |   VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM 
5cd3:A   (PRO148) to   (PRO212)  STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7  |   VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM 
5cd3:E   (PRO148) to   (PRO212)  STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7  |   VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM 
1xh3:A   (GLU212) to   (TRP274)  CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501  |   IMMUNE SYSTEM 
3jwd:P   (PRO149) to   (PRO213)  STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY  |   HIV-1 VIRAL SPIKE, MOLECULAR MOTION, PROTEIN ARCHITECTURE, RECEPTOR- TRIGGERED ENTRY, TYPE 1 FUSION PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, VIRAL PROTEIN 
2ypk:A   (GLU212) to   (TRP274)  STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS  |   IMMUNE SYSTEM, MICROPOLYMORPHISM 
2ypl:A   (GLU212) to   (TRP274)  STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, MICROPOLYMORPHISM 
4oaw:C   (GLU143) to   (ASN210)  FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158  |   IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM 
2nw3:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   MHC, HLA-B*3508, IMMUNE SYSTEM 
1lcs:A     (ASN9) to   (LYS124)  RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS  |   ANTIPARALLEL BETA-SANDWICH GLYCOPROTEIN, VIRAL PROTEIN 
1ldp:H   (ASP212) to   (LEU272)  CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES  |   COMPLEX (MHC I/PEPTIDE), MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNOLOGY, CELLULAR IMMUNITY, PEPTIDE ANTIGEN, CELL SURFACE RECEPTOR, ANTIGEN RECEPTOR, ANTIGEN PRESENTATION 
2nx5:K   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
1leg:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE  |   MHC CLASS I MOLECULE WITH BOUND PEPTIDE, IMMUNE SYSTEM 
4od1:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY  |   FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM 
4ods:H   (GLU148) to   (LYS209)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
1lk2:A   (ASP212) to   (TRP274)  1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE  |   CLASS I MHC-PEPTIDE COMPLEX, HIGH RESOLUTION, ANISOTROPIC AND TLS REFINEMENT, IMMUNE SYSTEM 
4ofp:D   (PRO264) to   (GLY338)  CRYSTAL STRUCTURE OF SYG-2 D3-D4  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4ofy:D   (PRO264) to   (LYS324)  CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
1lo0:H   (GLY168) to   (PRO218)  CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX  |   CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
1lo2:H   (GLY168) to   (PRO218)  RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY  |   CATALYTIC ANTIBODY, FAB, RETRO-DIELS-ALDERASE, IMMUNE SYSTEM 
1lp9:A   (GLU212) to   (TRP274)  XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1  |   IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM 
1lp9:H   (GLU212) to   (TRP274)  XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1  |   IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM 
1m05:C   (GLU212) to   (TRP274)  HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT  |   MHC CLASS I, HLA B8, EPSTEIN BARR VIRUS, IMMUNE SYSTEM 
4okv:B   (ASN150) to   (ASN217)  CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY  |   MALARIA VECTOR MOSQUITO, COLLAGEN BINDING PROTEIN, BLOOD CLOTTING 
4onh:B   (HIS154) to   (GLY241)  CRYSTAL STRUCTURE OF DN6 TCR  |   IG FOLD, TCR, ANTIGEN RECOGNITION, MHC LIKE, IMMUNE SYSTEM 
1xr9:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B62, HLA-B*1501, COMPLEX (ANTIGEN-PEPTIDE), IMMUNE SYSTEM-LIGASE COMPLEX 
1m6o:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE  |   MHC I, GLYCOPROTEIN, SIGNAL, IMMUNE SYSTEM 
1m7d:B   (PRO149) to   (GLY212)  CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE  |   FAB-CARBOHYDRATE INTERACTIONS, SHIGELLA O-ANTIGEN, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
2zok:G   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510  |   IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE 
4osu:L   (THR148) to   (ALA210)  CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT  |   IMMUNOGLOBULIN, IMMUNE RESPONSE, HCMV NEUTRALIZATION, HCMV GLYCOPROTEIN B, IMMUNE SYSTEM 
2zpk:H   (PRO149) to   (PRO212)  CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE  |   MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM 
4otx:L   (ASN145) to   (ARG211)  STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT  |   ANTIBODY, IMMUNE SYSTEM, LIPOPOLYSACCHARIDE, INTERNAL EPITOPE 
1mam:L   (ILE144) to   (ASN212)  CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN  |   IMMUNOGLOBULIN 
5czx:C   (GLY168) to   (PRO219)  CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB  |   ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM 
2zsv:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598  |   IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED 
2zsv:C   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598  |   IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED 
2zsw:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598  |   IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED 
2zsw:E   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598  |   IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED 
2zsw:C   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598  |   IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED 
2zsw:G   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598  |   IG FOLD, PROTEIN-PROTEIN INTERACTIONS, IMMUNE SYSTEM, SUBDOMINANT EPITOPE,GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED 
3kla:D   (GLU212) to   (TRP274)  CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR  |   MHC, TUMOUR, IMMUNOLOGY, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1mhc:A   (ASP212) to   (TRP274)  MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION  |   HISTOCOMPATIBILITY ANTIGEN/PEPTIDE, HISTOCOMPATIBILITY ANTIGEN- PEPTIDE COMPLEX 
1mhc:D   (ASP212) to   (TRP274)  MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION  |   HISTOCOMPATIBILITY ANTIGEN/PEPTIDE, HISTOCOMPATIBILITY ANTIGEN- PEPTIDE COMPLEX 
1mim:H   (PRO151) to   (PRO215)  IGG FAB FRAGMENT (CD25-BINDING)  |   IMMUNOGLOBULIN, C REGION 
4aei:J   (GLY169) to   (VAL218)  CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX  |   IMMUNE SYSTEM-TOXIN COMPLEX, ALPHA-TOXIN, CONFORMATIONAL REARRANGEMENT, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE-ACTIVATED SODIUM CHANNEL 
1mjj:B   (GLY169) to   (PRO227)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
5d2l:A   (ILE213) to   (TRP274)  CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2  |   TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM 
5d2l:G   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2  |   TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM 
5d2n:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX  |   TCR, NLV, HLA-A2, IMMUNE SYSTEM 
1mlc:D   (GLY165) to   (PRO215)  MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME  |   COMPLEX (ANTIBODY/ANTIGEN) 
4p3d:A   (PRO154) to   (PRO217)  MT1-MMP:FAB COMPLEX (FORM II)  |   IMMUNE SYSTEM 
3kpm:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpn:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpo:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpq:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM-PEPTIDE COMPLEX 
3kpr:F   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE  |   HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM 
5d4q:B   (PRO271) to   (LYS338)  CRYSTAL STRUCTURE OF GASDALIE IGG1 FC  |   ADCC, IGG FC, IMMUNE SYSTEM 
5d72:N   (GLY142) to   (PRO208)  CRYSTAL STRUCTURE OF MOR04252, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF  |   GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM 
4pb0:L   (ASP143) to   (ARG211)  STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53  |   ANTIBODY, IMMUNE SYSTEM 
1mwa:I   (ASP212) to   (TRP274)  2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX  |   IG DOMAIN, ANTIGEN RECOGNITION, COMPLEMENTARITY DETERMINING REGION, IMMUNE SYSTEM 
5d9q:L   (THR146) to   (PRO209)  CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46  |   HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM 
5d9q:H   (PRO147) to   (PRO211)  CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46  |   HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM 
5d9q:F   (PRO147) to   (PRO211)  CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46  |   HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM 
3kww:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE  |   MHC-PEPTIDE, HLA, DISULFIDE BOND, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1yn6:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE  |   MHC CLASS 1, H2-DB, INFLUENZA A, PEPTIDE OF ACID POLYMERASE, IMMUNE SYSTEM 
1yn7:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE  |   MHC CLASS 1, H2-DB, INFLUENZA A, PEPTIDE OF ACID POLYMERASE, IMMUNE SYSTEM 
5dd1:H   (PRO149) to   (ILE213)  CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES  |   HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM 
3kyn:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM 
3kyo:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM 
3kyo:C   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM 
5ddh:A   (ASP227) to   (TRP274)  STRUCTURE OF HLA-A2:01 WITH THE 12-MER PEPTIDE F12K  |   MHC, IMMUNE SYSTEM, PEPTIDE-PROTEIN COMPLEX 
1n2r:A   (GLU212) to   (TRP274)  A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION.  |   MHC I, SIGNAL, IMMUNE SYSTEM 
5deg:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF B*27:06 BOUND TO THE PVIPR PEPTIDE  |   IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2706 
4pg9:A   (ASP212) to   (TRP274)  MHC CLASS I IN COMPLEX WITH SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAL  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX 
4pgc:A   (ASP212) to   (TRP274)  MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(3,5-DIIODOTYROSINE)PAL  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX 
4pgc:D   (ASP212) to   (TRP274)  MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(3,5-DIIODOTYROSINE)PAL  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX 
4pgd:A   (ASP212) to   (TRP274)  MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAF  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX 
4pge:A   (ASP212) to   (TRP274)  MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAW  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX 
1n3n:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n3n:C   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n3n:E   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n3n:G   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n59:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
1n59:C   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
3l3d:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3g:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3i:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3j:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3k:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
5dja:A   (PRO271) to   (LYS338)  FC HETERODIMER DESIGN 9.1 Y407M + T366I  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djy:A   (PRO271) to   (LYS338)  FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djz:A   (PRO271) to   (LYS338)  FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dk0:A   (PRO271) to   (LYS338)  FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
1yy9:C   (ALA144) to   (ASN210)  STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225  |   CELL SURFACE RECEPTOR; TYROSINE KINASE; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
1yym:R  (GLY1162) to  (PRO1213)  CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, F23, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3l7f:A   (LYS145) to   (ARG211)  STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4am0:A   (SER153) to   (PRO216)  STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12  |   VIRAL PROTEIN, ANTIBODY, NEUTRALISATION 
4am0:E   (SER153) to   (PRO216)  STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12  |   VIRAL PROTEIN, ANTIBODY, NEUTRALISATION 
4pr5:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-D5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, STRUCTURAL BIOLOGY, IMMUNE SYSTEM 
4pra:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-Q5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4pre:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-Q5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4prn:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
3ld8:B   (ILE150) to   (LEU215)  STRUCTURE OF JMJD6 AND FAB FRAGMENTS  |   JMJD6, FAB FRAGMENTS, IMMUNE SYSTEM 
5dq9:B   (ASP143) to   (ARG211)  STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A  |   ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM 
5dq9:D   (ASP143) to   (ARG211)  STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A  |   ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM 
5dq9:L   (ASP143) to   (ARG211)  STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A  |   ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM 
3alu:A     (CYS1) to    (LEU51)  CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE  |   CEL-IV, C-TYPE LECTIN, RAFFINOSE, SUGAR BINDING PROTEIN 
3alu:C     (CYS1) to    (LEU51)  CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE  |   CEL-IV, C-TYPE LECTIN, RAFFINOSE, SUGAR BINDING PROTEIN 
4pv8:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX  |   TCR, T CELL, H2KB, HETEROCLITIC EPITOPES, CD8 T CELL, CORONAVIRUS, IMMUNE SYSTEM 
1zhb:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
1zhb:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
1zhb:G   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
1zhb:J   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
3lkn:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3lko:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3lkp:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1zhk:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY  |   T-CELL RECEPTOR, BULGED EPITOPES, IMMUNE SYSTEM 
1zhl:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY  |   T-CELL RECEPTOR, BULGED EPITOPES, IMMUNE SYSTEM 
3lkr:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
5dur:B   (PRO157) to   (PRO221)  INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4  |   INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM 
5dvl:A   (PRO271) to   (LYS338)  FC DESIGN 20.8.37 A CHAIN HOMODIMER Y349S/T366M/K370Y/K409V  |   HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM 
3ln4:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, PEPTIDE-BINDING MOTIFS, DISULFIDE BOND, IMMUNE SYSTEM 
3ln5:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, PEPTIDE-BINDING MOTIFS, DISULFIDE BOND, IMMUNE SYSTEM 
1zlu:M   (PRO151) to   (PRO227)  FAB 2G12 + MAN5  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM 
1zlw:H   (PRO151) to   (PRO227)  FAB 2G12 + MAN8  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM 
3lqa:L   (ALA149) to   (ALA213)  CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB  |   COMPLEX, POLY REACTIVITY, IMMUNE SYSTEM 
3lrs:B   (GLY142) to   (ALA207)  STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1  |   NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM 
1zsd:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX I, B35, B*3501, BULGED PEPTIDE, IMMUNE SYSTEM 
5e2v:H   (PRO149) to   (PRO213)  ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE  |   IMMUNE SYSTEM 
1zvs:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX  |   THE FIRST CLASS MHC, MAMU, TAT-TL8, IMMUNE SYSTEM 
3arb:A   (PRO217) to   (TRP279)  TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH  |   MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM 
3arg:A   (PRO217) to   (TRP279)  TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)  |   MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM 
3lv3:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, SECRETED, CALCIUM CHANNEL, VOLTAGE-GATED CHANNEL 
5e8d:H   (GLY167) to   (PRO217)  CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5  |   ANTIBODY, IMMUNOGLOBULIN, MONOCLONAL ANTIBODY, EPIDERMAL GROWTH FACTOR, CANCER, IMMUNE SYSTEM 
5e8n:G   (ASP212) to   (TRP274)  THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)  |   CANCER, NEO-EPITOPE, TAP-DEFICIENCY, TEIPP, MHC-I, SULFUR-PI INTERACTIONS, NON-CLASSICAL PEPTIDE BINDING, IMMUNE SYSTEM 
5e9d:A   (GLU212) to   (TRP274)  RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2  |   SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING 
5e9d:F   (GLU212) to   (TRP274)  RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2  |   SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING 
3m1b:E   (GLU207) to   (LEU267)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
4qex:H   (PRO148) to   (LYS208)  CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217  |   DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM 
4qex:I   (PRO148) to   (LYS208)  CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217  |   DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM 
4qf1:A   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF UNLIGANDED CH59UA, THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59  |   ANTI-HIV ANTIBODY, GP120, IMMUNE SYSTEM 
4qhk:M   (PRO149) to   (PRO213)  UCA (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
4qhk:O   (PRO149) to   (PRO213)  UCA (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
4qhk:K   (PRO149) to   (PRO213)  UCA (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
2a83:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX),HLA-B*2705 
3b3i:A   (GLU212) to   (TRP274)  CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES  |   HLA-B2709, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, G-PROTEIN COUPLED RECEPTOR, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, PROTEIN BINDING, IMMUNE SYSTEM 
3ma7:C   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D  |   GAMMA DELTA T CELLS, GLYCOLIPID PRESENTATION, MHC, CD1, CELL MEMBRANE, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM, DISULFIDE BOND, IMMUNITY 
3ma7:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D  |   GAMMA DELTA T CELLS, GLYCOLIPID PRESENTATION, MHC, CD1, CELL MEMBRANE, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM, DISULFIDE BOND, IMMUNITY 
4ba8:A    (GLU35) to   (LYS102)  HIGH RESOLUTION NMR STRUCTURE OF THE C MU3 DOMAIN FROM IGM  |   IMMUNE SYSTEM, IMMUNOGLOBULIN CONSTANT REGION 
2adg:B   (GLY162) to   (PRO212)  CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425  |   ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM 
3mcl:H   (GLY168) to   (PRO219)  ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3b6s:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SISTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
4qok:A   (GLU212) to   (ARG273)  STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM 
3mgo:G   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3mgt:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3mgt:G   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3mj9:H   (PRO151) to   (PRO227)  CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10  |   IMMUNOGLOBULIN TANDEM DOMAIN, RECEPTOR-ANTIBODY COMPLEX, CELL ADHESION, CELL JUNCTION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, COSTIMULATION, HAMSTER IGG, TRANSMEMBRANE, IMMUNE SYSTEM 
5enw:A   (ASP227) to   (TRP274)  STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9L  |   PEPTIDE COMPLEX, MHC, IMMUNE SYSTEM 
5eo0:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B0702-RFL9  |   TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
5eo1:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B0702-RL9  |   TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
3mlw:M   (THR145) to   (PRO208)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
4qrq:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL  |   HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM 
4qrs:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELK_IYM, ELKRKMIYM  |   HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM 
4qrt:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELN_YYM, ELNRKMIYM  |   HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM 
4qru:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELR_MYM, ELRRKMMYM  |   HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM 
3mod:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE  |   HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
3bgf:H   (GLY164) to   (PRO214)  X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB  |   ANTIGEN-ANTIBODY COMPLEX, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, VIRULENCE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
3bgf:B   (GLY164) to   (PRO214)  X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB  |   ANTIGEN-ANTIBODY COMPLEX, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, VIRULENCE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
5esz:H   (PRO149) to   (LYS210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244  |   HIV-1, ENV, V1V2, CH0219, CHAVI, IMMUNE SYSTEM 
5eu4:A   (ASP227) to   (TRP274)  HLA CLASS I ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5eu4:D   (ASP227) to   (TRP274)  HLA CLASS I ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5eu5:A   (ASP227) to   (TRP274)  HLA CLASS I ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
3mrb:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN 
3mrd:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN 
3mrf:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, EPSTEIN-BARR VIRUS, BMLF1 PROTEIN, EB2 PROTEIN 
3mrh:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN 
3mri:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN 
3mrk:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, TUMORAL PEPTIDE, ALPHA-FETOPROTEIN 
3mrr:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, PROSTAGLANDIN TRANSPORTER, TUMORAL PEPTIDE, MELAN-A ANALOGUE, MART1 ANALOGUE, SELF PEPTIDE 
3bn9:F   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2  |   ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE 
3bo8:A   (GLU212) to   (TRP274)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE  |   MELANOMA ASSOCIATED ANTIGEN, MAGE, MAGE-A1, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-A1, HLA-A010101, TCR, T-CELL RECEPTOR, ANTIBODY, FAB-HYB3, HYB3, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MEMBRANE, MHC I, SULFATION, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, TUMOR ANTIGEN, IMMUNE SYSTEM 
3bp4:A   (GLU212) to   (TRP274)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
3bp7:A   (GLU212) to   (TRP274)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B*2709, HLA-B2709, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A SIGNAL SEQUENCE, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
5f1n:A   (GLU213) to   (TRP275)  MHC COMLEXED TO 11MER PEPTIDE  |   MHC, IMMUNE SYSTEM 
5f3h:C   (PRO152) to   (PRO216)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
5f3h:E   (PRO152) to   (PRO216)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
5f3h:G   (PRO152) to   (PRO216)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
5f6j:F   (GLY146) to   (PRO212)  CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE  |   FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX 
3myj:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.  |   WT-1 PEPTIDE, R1Y MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3bvn:D   (GLU212) to   (ARG273)  HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*14, HLA-B1402, HLA-B*1402, PLMP2, ANKYLOSING SPONDYLITIS, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, CYTOPLASM, HOST-VIRUS INTERACTION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM 
3bw9:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12- MER PEPTIDE FROM THE PP65 PROTEIN  |   HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
4bsw:A   (ASP376) to   (LEU443)  HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2  |   IMMUNE SYSTEM, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, FC DOMAIN, IGG, IGG1, IMMUNOGLOBULIN G, ZYMEWORKS INC. 
3bxn:A   (GLU212) to   (TRP274)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEOKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*1402, HLA-B1402, HLA-B*14, PCATA, CATHEPSIN A, ANKYLOSING SPONDYLITIS, AUTOIMMUNITY, IMMUNE SYSTEM 
4r4f:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING, A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 YU2 GP120  |   HIV-1 ATTACHMENT PROTEIN, MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM- INHIBITOR COMPLEX 
4r7d:A   (PRO154) to   (PRO218)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7d:C   (PRO154) to   (PRO218)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7d:I   (PRO154) to   (ARG215)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
3c8k:A   (ASP212) to   (TRP274)  THE CRYSTAL STRUCTURE OF LY49C BOUND TO H-2KB  |   NATURAL KILLER CELL RECEPTOR; MHC; VIRUS; CRYSTAL STRUCTURE, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
4r7n:I   (GLY167) to   (PRO218)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
3c9n:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501  |   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HLA-B*1501, SARS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3ncy:Q   (PRO156) to   (VAL218)  X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT  |   MEMBRANE PROTEIN COMPLEX WITH FAB FRAGMENT, ARGININE AGMATINE ANTIPORTER, VIRTUAL PROTON PUMP, APC SUPERFAMILY, IMMUNE SYSTEM, TRANSPORT PROTEIN 
3cfb:H   (SER151) to   (LYS222)  HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K  |   IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER 
3cfb:B   (SER151) to   (LYS222)  HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K  |   IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER 
3nfp:A   (PRO152) to   (PRO216)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN  |   IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX 
3nfn:A   (GLU212) to   (TRP274)  RECOGNITION OF PEPTIDE-MHC BY A V-DELTA/V-BETA TCR  |   IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM 
3ngb:B   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120  |   HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4c55:B   (ASP376) to   (LEU443)  CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, ANTIBODY, IMMUNOGLOBULIN, IGG1 
4ris:H   (PRO149) to   (PRO213)  STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK  |   ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION 
3nps:B   (GLY162) to   (PRO213)  CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4  |   HYDROLASE, ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME-INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE, HYDROLASE - IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4cdh:B   (ASP157) to   (LEU224)  CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT  |   IMMUNE SYSTEM, C-LECTIN CRD, SIGN-R1, INMUNE SYSTEM, CAPSULAR POLYSACCHARIDE 
4rqq:B   (PRO154) to   (PRO218)  CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   IGG, ANTI-HIV-1 ANTIBODY, HIV-1 ENV TRIMER, IMMUNE SYSTEM 
3csy:D   (ALA144) to   (ARG211)  CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR  |   GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3nwm:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF A SINGLE CHAIN CONSTRUCT COMPOSED OF MHC CLASS I H-2KD, BETA-2MICROGLOBULIN AND A PEPTIDE WHICH IS AN AUTOANTIGEN FOR TYPE 1 DIABETES  |   MHC CLASS I, H-2KD, PEPTIDE-MHC COMPLEX, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3o4o:B   (ASP255) to   (LYS326)  CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX  |   CYTOKINE-RECEPTOR COMPLEX, BETA-TREFOIL, IG-LIKE FOLD, IMMUNE SYSTEM 
3d0l:B   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671  |   HIV, ANTIBODY, NEUTRALIZATION, EPITOPE, 2F5, GP41, IMMUNE SYSTEM 
3d18:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM-COMPLEX, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, IMMUNE SYSTEM 
3d25:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2  |   MHC, HLA-A2, SECONDARY ANCHOR RESIDUE, GLYCOPROTEIN, IMMUNE SYSTEM, MINOR HISTOCOMPATIBILITY ANTIGEN, STEM CELL TRANSPLANTATION, IMMUNE RESPONSE 
3d3v:A   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE  |   HTLV-1 TAX PEPTIDE, 3, 4-DIFLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T-CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM 
4s2s:H   (GLY168) to   (PRO218)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3o9w:A   (PRO217) to   (TRP279)  RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
3d6g:B   (ASP376) to   (LEU443)  FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.  |   FC FRAGMENT, IGG1, GLYCOSILATED PROTEIN, PROTEIN A MIMETIC PEPTIDE DENDRIMER LIGAND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
4cw1:A   (ASP223) to   (TRP270)  COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE  |   IMMUNE SYSTEM, MHC, B14 
4tnv:H   (PRO158) to   (LYS218)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION  |   MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4tnv:J   (PRO158) to   (PRO221)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION  |   MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4tnw:J   (PRO158) to   (ARG222)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION  |   MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
3of6:C   (HIS157) to   (TRP243)  HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE  |   IG FOLD, IMMUNE SYSTEM 
3dif:C   (ILE144) to   (ASN210)  CRYSTAL STRUCTURE OF FABOX117  |   ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4d2n:A   (ASP270) to   (LYS338)  CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1 
4tvp:E   (THR145) to   (PRO208)  CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22  |   HIV-1 ENVELOPE TRIMER, GP120, GP41, MEMBRANE FUSION, VIRAL ENTRY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, TYPE-1 MEMBRANE FUSION GLYCOPROTEIN 
3dnk:A   (ASP376) to   (SER442)  ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3do3:B   (GLU272) to   (LYS338)  HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE  |   IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
3drq:B   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION  |   HIV-1, 2F5, GP41, NMAB, IMMUNE SYSTEM 
4u1g:B   (GLY171) to   (PRO221)  PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1  |   MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM 
4u1h:A   (GLU212) to   (TRP274)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1j:A   (GLU212) to   (ARG273)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1k:A   (GLU212) to   (TRP274)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1m:A   (GLU212) to   (ARG273)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1n:A   (GLU212) to   (TRP274)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1s:A   (ASP227) to   (TRP274)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
5h94:A   (GLU213) to   (TRP275)  CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS  |   SWINE; CRYSTAL STRUCTURE; MHC I; INFLUENZA A VIRUS; MECHANISM; CTL IMMUNITY, IMMUNE SYSTEM 
3dtx:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM-COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA- B*2705, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, SECRETED, MHC I, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM 
3dx6:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dx8:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:F   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:K   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3ox8:D   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27  |   PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM 
3oxs:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27  |   PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM 
5hga:A   (GLU212) to   (TRP274)  HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hga:D   (GLU212) to   (TRP274)  HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgb:D   (GLU212) to   (TRP274)  HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgb:G   (GLU212) to   (TRP274)  HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgb:J   (GLU212) to   (TRP274)  HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgd:A   (GLU212) to   (TRP274)  HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgd:D   (GLU212) to   (TRP274)  HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgh:A   (GLU212) to   (TRP274)  HLA*A2402 COMPLEXED WITH HIV NEF138 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hho:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E  |   HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM 
4u6g:A   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE  |   10E8 ANTIBODY, HIV-1, HYDROCARBON-STAPLE, GP41 MPER, IMMUNE SYSTEM 
4u6h:A   (GLY168) to   (PRO218)  VACCINIA L1/M12B9-FAB COMPLEX  |   IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN 
4u6x:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH ALQDA, A 15 MER SELF- PEPTIDE  |   HLA A*0201, LIGANDOME, TCR, T CELL, IMMUNE SYSTEM 
4u6y:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH FLNDK, A 15 MER SELF- PEPTIDE  |   HLA A*0201, LIGANDOME, TCR, T CELL, IMMUNE SYSTEM 
3p30:L   (GLY158) to   (PRO208)  CRYSTAL STRUCTURE OF THE CLUSTER II FAB 1281 IN COMPLEX WITH HIV-1 GP41 ECTODOMAIN  |   HIV, GP41, CLUSTER 2, FAB, 6-HELIX BUNDLE, IMMUNE SYSTEM 
3p4m:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL, AN 8-MER PEPTIDE FROM THE LCMV  |   H2-KB, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM 
3p4o:D   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL, AN 8-MER MODIFIED PEPTIDE FROM THE LCMV  |   H2-KB, LCMV-V3A, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM 
3p9m:D   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4  |   H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM 
5i15:L   (GLU143) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4dvb:A   (GLY161) to   (VAL211)  THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112  |   IMMUNE SYSTEM, HYDROLASE 
5i5k:L   (LYS145) to   (GLY212)  STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB  |   COMPLEMENT, FAB, IMMUNE SYSTEM 
4uok:A   (GLY383) to   (PRO434)  ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4  |   IMMUNE SYSTEM, VIRAL PROTEIN, ALPHAVIRUS, VENEZUELAN, ANTIBODY NEUTRALIZATION, FAB 
3pnw:H   (PRO165) to   (PRO229)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
5i6x:B   (SER174) to   (PRO237)  X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE  |   MEMBRANE PROTEIN 
5i6z:B   (SER187) to   (PRO237)  X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER  |   MEMBRANE PROTEIN 
5i71:B   (SER174) to   (PRO237)  X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE  |   MEMBRANE PROTEIN 
5i73:B   (SER187) to   (PRO237)  X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES  |   MEMBRANE PROTEIN 
5i75:B   (SER174) to   (PRO237)  X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE  |   MEMBRANE PROTEIN 
5i8h:I   (PRO147) to   (PRO211)  CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB  |   HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
4uq2:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE  |   AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM 
4uq2:C   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE  |   AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM 
4uq3:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE  |   IMMUNE SYSTEM, AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE 
3pp3:I   (PRO155) to   (PRO219)  EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES  |   ANTIBODY FAB-FRAGMENT IG-DOMAIN, ANTIBODY, CD20, IMMUNE SYSTEM 
3pp4:H   (GLY168) to   (PRO219)  EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES  |   ANTIBODY FAB FRAGMENT IG-DOMAIN, CD20, CYCLIC PEPTIDE, ANTIBODY ANTIGEN, IMMUNE SYSTEM 
5icx:D   (PRO155) to   (PRO219)  CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4e5x:A   (ILE213) to   (TRP274)  CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX  |   AD2 E3-19K-HLA-A2 COMPLEX, UNIQUE TERTIARY STRUCTURE, ADENOVIRUS E3- 19K, IMMUNE EVASION FUNCTION, MHC CLASS I MOLECULE, ENDOPLASMIC RETICULUM, IMMUNE SYSTEM-TRANSCRIPTION COMPLEX 
3pqy:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224  |   H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM 
3pqy:F   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224  |   H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM 
5im7:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9, IMMUNE SYSTEM 
5im7:C   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9, IMMUNE SYSTEM 
3pwj:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT  |   HUD ANTIGEN, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwj:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT  |   HUD ANTIGEN, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwl:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwl:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwn:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, G2L MUTATION, PROTEIN BINDING 
3pwp:A   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwu:A   (GLU211) to   (TRP273)  AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801(BOLA-A11)  |   MHC BOLA CONFORMATION, IMMUNODOMINANT EPITOPE CATTLE, IMMUNE SYSTEM 
5inc:C   (GLU212) to   (ARG273)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9_S3T, IMMUNE SYSTEM 
5iop:D   (PRO155) to   (PRO219)  CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4elm:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
4ers:H   (PRO378) to   (PRO442)  A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR  |   GLUCAGON RECEPTOR, CLASS-B GPCR, FAB, GLYCOSYLATION, EXTRA-CELLULAR, IMMUNE SYSTEM 
4etq:A   (GLY169) to   (PRO219)  VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5  |   VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4evn:B   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:D   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:F   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:H   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:L   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:N   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:P   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
3qdj:A   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM 
4ezm:A   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4ezm:B   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
3qeh:A   (PRO149) to   (GLU212)  CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY  |   ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM 
3qfd:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, MELANOMA, IMMUNE SYSTEM 
3qfj:A   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE  |   TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, Y5F MUTATION, IMMUNE SYSTEM 
3qi9:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR  |   AUTOREACTIVITY, T-CELL SURFACE, IMMUNE SYSTEM 
5j6h:A   (ASP212) to   (TRP274)  RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C  |   IMMUNE SYSTEM 
4f7p:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009H1N1 PB1 (496-505)  |   HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS ALLELE RECOGNITION, IMMUNE SYSTEM 
4f7t:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)  |   HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS-ALLELE RECOGNITION, IMMUNE SYSTEM 
4f7t:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)  |   HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS-ALLELE RECOGNITION, IMMUNE SYSTEM 
3qq3:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES  |   SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF INFLUENZA VIRUS, IMMUNE SYSTEM 
3qq3:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES  |   SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF INFLUENZA VIRUS, IMMUNE SYSTEM 
3qum:B   (GLY163) to   (PRO213)  CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY  |   KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
3qux:A   (PRO217) to   (TRP279)  STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
4w4n:A   (ILE377) to   (LEU443)  CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A  |   HUMAN FC ASYMMETRY DYNAMICS IMMUNE MOLECULE, IMMUNE SYSTEM 
3qzw:A   (GLU212) to   (TRP274)  PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402  |   IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR 
3qzw:D   (GLU212) to   (TRP274)  PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402  |   IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR 
3r08:L   (ASP143) to   (ARG211)  CRYSTAL STRUCTURE OF MOUSE CD3EPSILON IN COMPLEX WITH ANTIBODY 2C11 FAB  |   CD3EPSILON, ANTIBODY, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM 
4fmk:A   (ARG184) to   (ARG249)  CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2  |   IMMUNOGLOBULIN-LIKE DOMAIN, IG DOMAIN, VIRAL ENTRY RECEPTOR, CELL ADHESION 
4fnl:L   (ALA144) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05  |   IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM 
3raj:H   (GLY169) to   (LYS216)  CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7  |   CD38, ADP-RIBOSYL CYCLASE, CYCLIC ADP-RIBOSE, X-CRYSTALLOGRAPHY, CALCIUM SIGNALING, AGONISTIC ANTIBODY, HB7, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4fp8:O   (ALA144) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3rew:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2  |   MHC CLASS I, TUMOUR ANTIGEN TARGETING, IMMUNE SYSTEM, HLA-A2, EPSTEIN BARR VIRUS, ALLOREACTIVITY, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, IMMUNOGLOBULIN DOMAIN 
3rew:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2  |   MHC CLASS I, TUMOUR ANTIGEN TARGETING, IMMUNE SYSTEM, HLA-A2, EPSTEIN BARR VIRUS, ALLOREACTIVITY, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, IMMUNOGLOBULIN DOMAIN 
4fqh:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR9114  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM 
4fqh:A   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF FAB CR9114  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM 
4fqr:d   (GLU143) to   (ARG211)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:h   (GLU143) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:r   (GLU143) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:t   (GLU143) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:v   (GLU143) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:x   (LYS145) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqv:I   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqv:N   (GLY142) to   (PRO208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqy:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3rgv:C   (ASP212) to   (TRP274)  A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS  |   TCR, MHC, MHC CLASS I, IMMUNE SYSTEM 
5jny:A   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF 10E8 FAB  |   MPER, HIV, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
4ftv:A   (GLU212) to   (TRP274)  THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE  |   TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, HIGH AFFINITY, C134, IMMUNE SYSTEM 
3ri5:H   (PRO158) to   (LYS218)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND PICROTOXIN  |   MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4g43:A   (PRO208) to   (SER269)  STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E  |   MHC I COMPLEX, NARROW BINDING GROOVE, IMMUNE SYSTEM 
4g9d:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B2705-KK10  |   TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
4g9f:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M  |   TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
5k9q:S   (PRO164) to   (PRO228)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
4gay:B   (ILE144) to   (ASN212)  STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33  |   ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2, IMMUNE SYSTEM 
4gkn:A   (GLU212) to   (TRP274)  A2-MHC COMPLEX CARRYING FATGIGIITV  |   MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM 
4gkn:D   (GLU212) to   (TRP274)  A2-MHC COMPLEX CARRYING FATGIGIITV  |   MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM 
4gko:B   (THR369) to   (PRO439)  CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4gko:D   (ASP473) to   (VAL541)  CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4gko:F   (LYS367) to   (PRO439)  CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4gks:A   (GLU212) to   (TRP274)  A2-MHC COMPLEX CARRYING FLTGIGIITV  |   MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM 
4grg:C   (THR369) to   (THR434)  CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79, AN ANTI-IGE INHIBITOR  |   IG-FOLD, IMMUNITY, HIGH/LOW AFFINITY RECEPTOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
4grg:C   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79, AN ANTI-IGE INHIBITOR  |   IG-FOLD, IMMUNITY, HIGH/LOW AFFINITY RECEPTOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
4grg:D   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79, AN ANTI-IGE INHIBITOR  |   IG-FOLD, IMMUNITY, HIGH/LOW AFFINITY RECEPTOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
5swq:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH NA231, AN INFLUENZA EPITOPE  |   HLA-A*02:01, CROSS-REACTIVITY, HETEROLOGOUS IMMUNITY, TCR, T CELL, IMMUNE SYSTEM 
5swz:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX  |   H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM 
5swz:F   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX  |   H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM 
5swz:K   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX  |   H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM 
5t3s:D   (PRO149) to   (PRO213)  HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022  |   HIV-1 NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
5t3x:L   (ALA144) to   (PRO209)  3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.  |   HIV, N-LINKED GLYCOSYLATION, BROADLY NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5t3z:L   (ALA144) to   (ALA208)  3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074  |   HIV, N-LINKED GLYCOSYLATION, BROADLY NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
8fab:B   (PRO157) to   (PRO221)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
1a1m:A   (GLU212) to   (TRP274)  MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B53, HIV, COMPLEX (ANTIGEN/PEPTIDE) 
2ak4:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
2ak4:F   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
2ak4:K   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
2ak4:Q   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
4gw1:D   (PRO155) to   (PRO219)  CQFD MEDITOPE  |   IGG, IMMUNE SYSTEM, EGFR 
3roo:C   (ASP212) to   (TRP274)  MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE  |   T-CELL RECEPTOR, MHC, GP34, NY-GP34, EPITOPE, POST-TRANSLATIONAL MODIFICATION, LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM, T CELL RECOGNITION, AUTOIMMUNITY, T CELL RECEPTOR, CELL SURFACE 
2ol3:H   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE  |   T CELL RECEPTOR, CLASS I MHC, H-2KBM8, TCR-PMHC COMPLEX, IMMUNE SYSTEM 
1agc:A   (GLU212) to   (TRP274)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1agf:A   (GLU212) to   (TRP274)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
2axg:A   (GLU212) to   (TRP274)  THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION  |   IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX 
2bck:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE  |   IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM 
2bck:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE  |   IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM 
4hdi:A   (ASP148) to   (ASN215)  CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS  |   IGG, FAB, IMMUNE SYSTEM 
4hdi:B   (PRO156) to   (ARG216)  CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS  |   IGG, FAB, IMMUNE SYSTEM 
2bnr:A   (GLU212) to   (TRP274)  STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES  |   IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES 
4huv:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF H2DB-NPM6W  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
2bvq:A   (GLU212) to   (TRP274)  STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION  |   GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE 
1of2:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN) 
3sdd:A   (PRO217) to   (TRP279)  CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE  |   CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, IMMUNE SYSTEM 
4xh2:E   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4i48:A   (ASP227) to   (TRP274)  STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV ENV DERIVED PEPTIDE  |   MONOMER, PEPTIDE PRESENTATION, IMMUNE SYSTEM 
3skm:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE HLA-B8FLRGRAYVL, MUTANT G8V OF THE FLR PEPTIDE  |   T CELL RECEPTOR, IMMUNE SYSTEM 
1cic:D   (PRO152) to   (PRO215)  IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225  |   IMMUNOGLOBULIN, FAB COMPLEX, IDIOTOPE, ANTI-IDIOTOPE 
3spv:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A PEPTIDE-HLA COMPLEX  |   IMMUNOLOGY, RECEPTOR, HLA, HLA-B*0801, EBV, MHC, TCR, T CELL, IMMUNE SYSTEM 
3g04:B   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY  |   TSH RECEPTOR, GPCR, THYROID, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR- AUTOANTIBODY COMPLEX, IMMUNE SYSTEM 
2ckb:H   (ASP212) to   (TRP274)  STRUCTURE OF THE 2C/KB/DEV8 COMPLEX  |   T CELL ANTIGEN RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX 
2ckb:I   (ASP212) to   (TRP274)  STRUCTURE OF THE 2C/KB/DEV8 COMPLEX  |   T CELL ANTIGEN RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX 
3t4y:A   (ILE143) to   (ASN209)  S25-2- KDO MONOSACCHARIDE COMPLEX  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM 
3gjf:D   (ASP227) to   (TRP274)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3gjf:L   (VAL147) to   (PRO211)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3gjf:M   (PRO155) to   (PRO219)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3gml:A   (PRO217) to   (TRP279)  STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH  |   CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, SECRETED, IMMUNE SYSTEM 
3gmo:A   (PRO217) to   (TRP279)  STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF  |   CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
3tbt:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbt:J   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
2r4r:H   (GLY162) to   (PRO212)  CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR  |   TRANSMEMBRANE HELIX, G-PROTEIN COUPLED RECEPTOR, GLYCOPROTEIN, LIPOPROTEIN, PALMITATE, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, SIGNALING PROTEIN 
3gsn:B   (HIS154) to   (GLY241)  CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE  |   HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3gso:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE  |   HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
2ddq:H   (GLY162) to   (PRO212)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT  |   MONOCLONAL ANTIBODY, 4-HYDROXY-2-NONENAL, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3tie:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB  |   ANTIGEN PRESENTATION, PEPTIDE BINDING, IGG, MHC, IMMUNE SYSTEM 
2dyp:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G  |   IMMUNOGLOBULIN-LIKE, IMMUNE SYSTEM 
4jrx:A   (ILE213) to   (TRP274)  CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX  |   TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM 
1qr1:A   (ILE213) to   (TRP274)  POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE  |   PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM 
1qr1:D   (GLU212) to   (TRP274)  POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE  |   PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM 
3h7b:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3h7b:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3u0w:H   (PRO149) to   (PRO213)  AD RELATED MURINE ANTIBODY FRAGMENT  |   IMMUNOGLOBULIN, ANTIBODY, AMYLOID BETA, ALZHEIMER, IMMUNE SYSTEM 
3h9z:A   (VAL370) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3h9z:A   (ASP473) to   (VAL543)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3h9z:D   (VAL370) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1ffo:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, CRYSTALLOGRAPHY, PEPTIDE BINDING, T CELL RECEPTOR, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX 
1fg2:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
1fg2:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
1fg2:G   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
1fg2:J   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
2v2w:D   (GLU212) to   (TRP274)  T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT  |   IMMUNOGLOBULIN DOMAIN, COMPLEX (ANTIGEN-PEPTIDE), TCR, HIV, MHC, AIDS, MHC I, HLA-A2, MEMBRANE, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM, COMPLEX (ANTIGEN/PEPTIDE), UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE 
1rk0:A   (ASP212) to   (TRP274)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE  |   MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM 
1fzo:A   (ASP212) to   (TRP274)  MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
3upr:A   (GLU212) to   (TRP274)  HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR  |   HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM 
3upr:C   (GLU212) to   (TRP274)  HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR  |   HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM 
4ki1:A   (ASP473) to   (VAL543)  PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4ki1:B   (ASP473) to   (VAL543)  PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4ki1:C   (ASP473) to   (VAL543)  PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
3utq:A   (ASP227) to   (TRP274)  HUMAN HLA-A*0201-ALWGPDPAAA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, IMMUNE SYSTEM 
1s7s:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
3v5h:D   (GLU212) to   (TRP274)  HLA-A2.1 KVAEIVHFL  |   PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM 
2vr4:A   (LYS722) to   (ARG777)  TRANSITION-STATE MIMICRY IN MANNOSIDE HYDROLYSIS: CHARACTERISATION OF TWENTY SIX INHIBITORS AND INSIGHT INTO BINDING FROM LINEAR FREE ENERGY RELATIONSHIPS AND 3-D STRUCTURE  |   LINEAR FREE ENERGY RELATIONSHIP, HYDROLASE, TRANSITION STATE MIMIC, MANNOSIDASE, GLYCOSIDE HYDROLASE 
2vuo:A   (PRO271) to   (LYS338)  CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT  |   IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, IGG, RABBIT, FC FRAGMENT, GLYCOSYLATION, IMMUNOGLOBULINS, IMMUNOGLOBULIN DOMAIN 
2vuo:B   (PRO271) to   (LYS338)  CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT  |   IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, IGG, RABBIT, FC FRAGMENT, GLYCOSYLATION, IMMUNOGLOBULINS, IMMUNOGLOBULIN DOMAIN 
3ve0:A   (GLY168) to   (PRO218)  CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN BONIFACE) BOUND TO 16F6  |   EBOLA, SUDAN, GLYCOPROTEIN, VIRUS SURFACE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
1t1y:A   (ASP227) to   (TRP274)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
4l29:A   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:C   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:I   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:K   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:Q   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:U   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:W   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:Y   (GLU212) to   (TRP274)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l3c:C   (GLU212) to   (TRP274)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:K   (GLU212) to   (TRP274)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:S   (GLU212) to   (TRP274)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:W   (GLU212) to   (TRP274)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:Y   (GLU212) to   (TRP274)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4zpv:A   (PRO149) to   (PRO212)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2gt9:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE  |   MELAN-A/MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASSI, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
2gt9:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE  |   MELAN-A/MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASSI, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
2gtw:A   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A27L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
2gtw:D   (GLU212) to   (TRP274)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A27L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
2w59:B   (GLY393) to   (TYR447)  STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT  |   IMMUNOGLOBULIN, AVIAN, IGY FC, IMMUNE SYSTEM 
1tjg:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE  |   2F5; ANTIBODY; GP41; HIV-1; NEUTRALIZING; MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
2h2s:E   (GLY170) to   (PRO220)  CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-  |   CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT 
1hi6:B   (GLY161) to   (PRO211)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIBODY/PEPTIDE), POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
3iu3:H   (GLY164) to   (PRO215)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN  |   IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM 
1hsa:A   (GLU212) to   (TRP274)  THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC  |   HISTOCOMPATIBILITY ANTIGEN 
1hsa:D   (GLU212) to   (TRP274)  THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC  |   HISTOCOMPATIBILITY ANTIGEN 
2hjl:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE  |   B57, HLA, HIV, IMMUNE SYSTEM 
1i1f:D   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y  |   HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM 
2wqr:A   (ASP473) to   (VAL543)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN 
2wqr:B   (ASP473) to   (VAL543)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN 
4lvo:C   (GLY169) to   (PRO219)  CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2  |   ALPHA BETA, ENZYME-PRODOMAIN COMPLEX, ROSSMANN FOLD, SERINE PROTEASE, CALCIUM IONS, PRODOMAIN, PARASITOPHOROUS VACUOLE, HYDROLASE- INHIBITOR-IMMUNE SYSTEM COMPLEX 
3wfb:H   (GLY173) to   (PRO223)  REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT  |   METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX 
1uxw:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM-PEPTIDE COMPLEX, COMPLEX (ANTIGEN/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2709 
4mhj:K   (PRO151) to   (PRO227)  CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)  |   H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3wjj:C   (LYS117) to   (THR168)  CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
1vad:A   (ASP212) to   (TRP274)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE  |   HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, PEPTIDE, COMPLEX (MHC I/PEPTIDE) COMPLEX 
4mng:A   (PRO215) to   (TRP277)  STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE  |   IMMUNGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, CD1, IMMUNOLOGICAL, LYMPHOCYTES, GAMMA DELTA T CELL, T CELL RECOGNITION, SELF- RECOGNITION, MYELIN, INTESTINAL EPITHELIAL LYMPHOCYTES, HUMAN, LIPID BINDING, SELF-LIGAND,, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM 
4mng:C   (PRO215) to   (TRP277)  STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE  |   IMMUNGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, CD1, IMMUNOLOGICAL, LYMPHOCYTES, GAMMA DELTA T CELL, T CELL RECOGNITION, SELF- RECOGNITION, MYELIN, INTESTINAL EPITHELIAL LYMPHOCYTES, HUMAN, LIPID BINDING, SELF-LIGAND,, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM 
1vgk:A   (ASP212) to   (TRP274)  THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION  |   MHC, H-2KD, CRYSTAL STRUCTURE, CLASS I, IMMUNE SYSTEM 
2xfx:A   (GLU212) to   (TRP274)  CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA  |   IMMUNE SYSTEM, MAJOR HISTOCOMPATIBILITY, EAST COAST FEVER, THEILERIOSIS 
3wuw:A   (GLU212) to   (TRP274)  KIR3DL1 IN COMPLEX WITH HLA-B*57:01.I80T  |   IMMUNE RECEPTOR COMPLEX, PROTEIN BINDING 
2jix:G   (GLU143) to   (ARG211)  CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR  |   IMMUNE SYSTEM, RECEPTOR, TRANSMEMBRANE, RECEPTOR SOLUBLE DOMAIN, ANTIBODY, RECEPTOR-IMMUNE SYSTEM COMPLEX 
5c0g:A   (ASP227) to   (TRP274)  HLA-A02 CARRYING YLGGPDFPTI  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
4nny:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2  |   NONPHOSPHORYLATED EPITOPE, PEPTIDE-MHC COMPLEX, MHC, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, IMMUNE SYSTEM-ANTIGEN COMPLEX 
1kpv:A   (ASP212) to   (TRP274)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/SEV9  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE-MHC, IMMUNE SYSTEM 
5c7x:M   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF MOR04357, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF  |   GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM 
3jts:A   (GLU212) to   (TRP274)  GY9-MAMU-A*02-HB2M  |   ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3jts:D   (GLU212) to   (TRP274)  GY9-MAMU-A*02-HB2M  |   ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1lek:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8  |   MHC CLASS I ALLOGENEIC COMPLEX WITH PEPTIDE, IMMUNE SYSTEM 
2zuq:F   (PRO155) to   (LYS215)  CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX  |   DISULFIDE BOND, MEMBRANE PROTEIN, FAB, E. COLI, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE, REDOX-ACTIVE CENTER, TRANSMEMBRANE, TRANSPORT, OXIDOREDUCTASE/IMMUNE SYSTEM COMPLEX 
1mhe:A   (GLU212) to   (TRP274)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, HLA E, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HLA, BETA 2 MICROGLOBULIN, PEPTIDE, LEADER PEPTIDE, NON- CLASSICAL MHC, CLASS IB MHC 
1mhe:C   (GLU212) to   (TRP274)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, HLA E, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HLA, BETA 2 MICROGLOBULIN, PEPTIDE, LEADER PEPTIDE, NON- CLASSICAL MHC, CLASS IB MHC 
1mlb:B   (PRO152) to   (PRO215)  MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3kpl:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, IMMUNE SYSTEM 
3kpp:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM 
1ydp:A   (GLU212) to   (TRP274)  1.9A CRYSTAL STRUCTURE OF HLA-G  |   IMMUNE SYSTEM 
1ymh:B   (GLY162) to   (PRO212)  ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W  |   ENGINEERING OF CRYSTAL CONTACTS, PPL-FAB COMPLEX, IMMUNE SYSTEM 
3kxf:C   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER  |   MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3kxf:I   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER  |   MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
5def:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF B*27:04 COMPLEX BOUND TO THE PVIPR PEPTIDE  |   IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2704 
5dfv:E  (PRO1035) to  (PRO1098)  CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04  |   HELICAL BUNDLE, CELL ADHESION, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
1n5a:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
1n5a:G   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
1n5a:J   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
4prb:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-A4  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4prd:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-D5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
3lex:H   (PRO148) to   (PRO211)  2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41  |   HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN 
3lex:A   (GLY161) to   (PRO211)  2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41  |   HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN 
3lkq:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3lks:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
5dvn:A   (PRO271) to   (SER337)  FC K392D/K409D HOMODIMER  |   HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IGG1_FC - NONE, IMMUNE SYSTEM 
1zs8:A   (ASP211) to   (TRP273)  CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM 
1zs8:C   (ASP211) to   (TRP273)  CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM 
1zs8:E   (ASP211) to   (TRP273)  CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM 
1zs8:G   (ASP211) to   (TRP273)  CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM 
1zs8:I   (ASP211) to   (TRP273)  CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, VOMERONASAL ORGAN, VNO, V2R RECEPTORS, PHEROMONE RECEPTORS, BETA-2-MICROGLOBULIN, PEPTIDES, IMMUNE SYSTEM 
4qgt:A   (ASP376) to   (LEU443)  THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON  |   IGG1, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, IMMUNE SYSTEM 
3mlv:N   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
3mlx:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
3bh9:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2  |   PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM 
3bhb:A   (ASP227) to   (TRP274)  CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2  |   PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM 
3mv8:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG  |   HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM 
3bwa:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8- MER PEPTIDE FROM THE PP65 PROTEIN  |   HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3ch1:A   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100  |   MHC, H-2DB, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, MELANIN BIOSYNTHESIS, IMMUNE SYSTEM 
5fyl:H   (PRO147) to   (LYS207)  CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22  |   VIRAL PROTEIN, HIV, ENVELOPE, GLYCAN, TRIMER 
3dmm:A   (ASP212) to   (TRP274)  CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX  |   T CELL CO-RECEPTOR CD8AB MHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, ENVELOPE PROTEIN, ALTERNATIVE SPLICING, POLYMORPHISM, IMMUNE SYSTEM 
3dx7:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3p4n:D   (ASP212) to   (ARG273)  CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM, AN 8-MER PEPTIDE FROM PV  |   H2-KB, PV, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM 
5hys:J   (ASP473) to   (VAL543)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:K   (GLY368) to   (THR434)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
4e0r:D   (ASP223) to   (TRP270)  STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401  |   MHC I COMPLEX, NARROW BINDING GROOVE, IMMUNE SYSTEM 
5i74:B   (SER187) to   (PRO237)  X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE  |   MEMBRANE PROTEIN 
5id0:D   (PRO155) to   (PRO219)  CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5ind:C   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9_E5D, IMMUNE SYSTEM 
3qul:D   (ASP212) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, T CELL RECEPTOR, CELL SURFACE 
3quy:A   (PRO217) to   (TRP279)  STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
3quz:A   (PRO217) to   (TRP279)  STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
5jsa:A   (PRO151) to   (PRO227)  UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128  |   HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4g6f:H   (PRO149) to   (PRO213)  CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE  |   IMMUNOGLOBULIN, MPER, ANTIBODY, IMMUNE SYSTEM 
4g8i:A   (GLU212) to   (TRP274)  CRYSTAL STRUCTURE OF HLA B2705-KK10-L6M  |   TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM